Nutraceutical Ingredients Market by Ingredient Type, Application, Source, Function, and Region

List of Tables

The nutraceutical ingredients market is projected to grow from USD 108.33 billion in 2026 to USD 161.53 billion in 2031, at a CAGR of 7.3%.

Scope of the Report
Years Considered for the Study	2022-2031
Base Year	2025
Forecast Period	2026-2031
Units Considered	Value (USD Million/Billion), Volume (Tons)
Segments	By Ingredient Type, Application, Source, Function, and Region
Regions covered	North America, Asia Pacific, Europe, South America, RoW

"Expanding use of amino acids in sports and specialized nutrition is expected to drive market growth"

Amino acids are increasingly incorporated into sports nutrition, dietary supplements, and specialized nutrition products, particularly formulations designed to support muscle recovery, physical performance, and protein intake. Branched-chain amino acids, essential amino acids, non-essential amino acids, and specialty amino acids are used across a range of formulations, with branched-chain amino acids particularly common in sports nutrition products targeting exercise performance and recovery. Their availability in standardized and high-purity forms enables manufacturers to develop products in powders, capsules, tablets, and functional beverages. In addition, advances in fermentation-based production are improving the efficiency, consistency, and scalability of amino acid manufacturing, supporting the availability of ingredients for different formulation requirements. The continued development of sports nutrition, active-aging, and specialized nutrition products is further broadening the use of amino acids across nutraceutical applications.

"Established nutritional and functional benefits of animal-based nutraceutical ingredients to support market growth."

By source, the animal-based segment accounts for a significant share of the nutraceutical ingredients market, supported by the high nutritional value, bioavailability, and established functional benefits of animal-derived ingredients. Animal-based sources provide a range of high-value nutrients and bioactive compounds used in products targeting joint, bone, muscle, cardiovascular, skin, and cognitive health. Their established use in sports nutrition is further supporting demand, particularly for protein-based products such as protein powders, meal replacements, and recovery beverages. Animal-derived ingredients also have an important role in infant and early-life nutrition, where dairy proteins and specialized components are used in formulations designed to support growth and development. In addition, their use in medical and specialized nutrition is supported by their nutritional quality and established scientific evidence, particularly in products addressing malnutrition, muscle loss, recovery, and age-related nutritional needs. These established applications across sports, infant, medical, and healthy-aging nutrition continue to sustain demand for animal-based nutraceutical ingredients.

"North America is expected to account for a significant share of the nutraceutical ingredients market due to strong consumer demand and an established nutraceutical industry."

North America is expected to account for a significant share of the nutraceutical ingredients market, supported by strong consumption of dietary supplements, high consumer awareness of preventive healthcare, and growing demand for functional nutrition products. The region has a well-established market for dietary supplements used across immunity, heart health, digestive wellness, sports nutrition, and healthy aging applications. High disposable incomes and healthcare spending support consumer willingness to spend on premium wellness, nutrition, and health products. In addition, the established functional food and beverage market, including protein-fortified foods, probiotic products, functional dairy products, energy and sports drinks, and fortified beverages, creates consistent demand for nutraceutical ingredients. The growing aging population is further increasing demand for products supporting joint, bone, cognitive, cardiovascular, and healthy aging needs, while the strong sports and active nutrition industry supports the use of protein ingredients, amino acids, and functional nutrition ingredients.

In-depth interviews were conducted with chief executive officers (CEOs), directors, and managers from various key organizations operating in the nutraceutical ingredients market.

By Company Type: Tier 1 - 25%, Tier 2 - 45%, and Tier 3 - 30%
By Designation: Directors- 35%, C-level - 40%, Others - 25%
By Region: North America - 20%, Europe - 25%, Asia Pacific - 35%, South America - 15%, and Rest of the World -5%

Prominent companies in the nutraceutical ingredients market include Cargill, Incorporated (US), ADM (US), International Flavors & Fragrances Inc. (US), BASF SE (Germany), Glanbia PLC (Ireland), Arla Foods amba (Denmark), dsm-firmenich (Netherlands), Ingredion Incorporated (US), Tate & Lyle PLC (UK), Roquette Freres (France), Associated British Foods PLC (UK), Fonterra Co-operative Group Limited (New Zealand), Kerry Group PLC (Ireland), Novonesis Group (Denmark), Balchem Corporation (US), Ajinomoto Co., Inc. (Japan), Divi's Laboratories Limited (India), Kemin Industries (US), GELITA AG (Germany), BENEO GmbH (Germany), Cosucra Groupe Warcoing SA (Belgium), Conagen Inc. (US), Sarshika Pharmachem LLP (India), Canurta Naturals USA (US), and EVANIUM (US).

Research Coverage

This research report categorizes the nutraceutical ingredients market, by ingredient type (functional proteins, omega-3 fatty acids, probiotics, prebiotics, fibers & specialty carbohydrates, vitamins [vitamin A, vitamin B, vitamin C, vitamin D, vitamin E, and others], minerals [calcium, magnesium, iron, zinc, other minerals], amino acids [branched-chain amino acids, essential amino acids, non-essential amino acids, specialty amino acids], carotenoids, other types), source (plant-based, animal-based, microbial-based, synthetics), function (nutritional support, digestive health, immune health, cardiovascular health, bone & joint health, cognitive & mental health, sports & performance, weight management, others), and application (human nutrition [dietary supplements, functional foods, functional beverages, medical & specialized nutrition, infant & early-life nutrition], animal nutrition [companion animal nutrition, livestock nutrition, aquaculture nutrition, other animal nutrition]), and region (North America, Europe, Asia Pacific, South America, RoW).

The report's scope encompasses detailed information on the major factors, including drivers, restraints, challenges, and opportunities, which influence the growth of the nutraceutical ingredients industry. A thorough analysis of the key industry players was done to provide insights into their business, services, key strategies, contracts, partnerships, agreements, product launches, mergers & acquisitions, and recent developments associated with the nutraceutical ingredients market. This report provides a competitive analysis of emerging startups in the nutraceutical ingredients market ecosystem. Furthermore, the study covers industry-specific trends, including technology analysis, ecosystem & market mapping, and patent & regulatory landscape, among others.

Reasons to Buy This Report

The report provides market leaders/new entrants with information on the closest approximations of revenue numbers for the overall nutraceutical ingredients and their subsegments. It will help stakeholders understand the competitive landscape and gain more insights to better position their businesses and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, restraints, challenges, and opportunities.

The report provides insights into the following pointers:

Analysis of key drivers (increasing adoption of dietary supplements and targeted health products, Growing demand for fortified and functionally enhanced foods and beverages), restraints (higher costs associated with fortification and functional formulation, stringent regulatory requirements and health-claim restrictions), opportunities (widespread micronutrient deficiencies and continued use of fortification and supplementation, growing demand for preventive and healthy aging nutrition), and challenges (advancements in delivery technologies enhancing bioavailability and stability of nutraceutical ingredients, variability and quality-control challenges for botanical and natural ingredients)
Product Development/Innovation: Detailed insights into research & development activities and new product launches in the nutraceutical ingredients market
Market Development: Comprehensive information about lucrative markets, by offering analysis of nutraceutical ingredients across varied regions
Market Diversification: Exhaustive information about product sources, geographies, recent developments, and investments in the nutraceutical ingredients market
Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings, brand/product comparison, and product footprints of leading players such as Cargill, Incorporated (US), ADM (US), International Flavors & Fragrances Inc. (US), BASF SE (Germany), Glanbia PLC (Ireland), Arla Foods amba (Denmark), dsm-firmenich (Netherlands), Ingredion Incorporated (US), Tate & Lyle PLC (UK), Roquette Freres (France), Associated British Foods PLC (UK), Fonterra Co-operative Group Limited (New Zealand), Kerry Group PLC (Ireland), Novonesis Group (Denmark), Balchem Corporation (US) and other players in the nutraceutical ingredients market

Product Code: FB 2211

1 INTRODUCTION

1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.3 STUDY SCOPE
- 1.3.1 INCLUSIONS AND EXCLUSIONS
- 1.3.2 YEARS CONSIDERED
1.4 CURRENCY CONSIDERED
1.5 UNIT CONSIDERED
1.6 STAKEHOLDERS
1.7 SUMMARY OF CHANGES

2 EXECUTIVE SUMMARY

2.1 MARKET HIGHLIGHTS AND KEY INSIGHTS
2.2 KEY MARKET PARTICIPANTS: MAPPING OF STRATEGIC DEVELOPMENTS
2.3 DISRUPTIVE TRENDS IN NUTRACEUTICAL INGREDIENTS MARKET
2.4 HIGH-GROWTH SEGMENTS
2.5 REGIONAL SNAPSHOT: MARKET SIZE, GROWTH RATE, AND FORECAST

3 PREMIUM INSIGHTS

3.1 ATTRACTIVE OPPORTUNITIES FOR PLAYERS IN NUTRACEUTICAL INGREDIENTS MARKET
3.2 NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE AND REGION
3.3 NUTRACEUTICAL INGREDIENTS MARKET, BY SOURCE
3.4 NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE
3.5 NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION
3.6 NUTRACEUTICAL INGREDIENTS MARKET, BY COUNTRY

4 MARKET OVERVIEW

4.1 INTRODUCTION
4.2 MARKET DYNAMICS
- 4.2.1 DRIVERS
  - 4.2.1.1 Increasing adoption of dietary supplements and targeted health products
  - 4.2.1.2 Growing demand for fortified and functionally enhanced foods and beverages
  - 4.2.1.3 Rising incidence of chronic diseases
- 4.2.2 RESTRAINTS
  - 4.2.2.1 High Cost and price volatility of nutraceutical ingredients
  - 4.2.2.2 Stringent regulatory requirements and health-claim restrictions
- 4.2.3 OPPORTUNITIES
  - 4.2.3.1 Widespread micronutrient deficiencies and continued use of fortification and supplementation
  - 4.2.3.2 Growing demand for preventive and healthy aging nutrition
  - 4.2.3.3 Advancements in delivery technologies enhancing bioavailability and stability of nutraceutical ingredients
- 4.2.4 CHALLENGES
  - 4.2.4.1 Variability and quality-control challenges for botanical and natural ingredients
  - 4.2.4.2 Supply chain disruptions and availability of nutraceutical raw materials
4.3 UNMET NEEDS AND WHITE SPACES
- 4.3.1 UNMET NEEDS IN NUTRACEUTICAL INGREDIENTS MARKET
- 4.3.2 WHITE SPACE OPPORTUNITIES
4.4 INTERCONNECTED MARKETS AND CROSS-SECTOR OPPORTUNITIES
- 4.4.1 INTERCONNECTED MARKETS
- 4.4.2 CROSS-SECTOR OPPORTUNITIES
4.5 STRATEGIC MOVES BY TIER-1/2/3 PLAYERS
- 4.5.1 KEY MOVES AND STRATEGIC FOCUS

5 INDUSTRY TRENDS

5.1 INTRODUCTION
5.2 PORTER'S FIVE FORCES ANALYSIS
- 5.2.1 THREAT OF NEW ENTRANTS
- 5.2.2 THREAT OF SUBSTITUTES
- 5.2.3 BARGAINING POWER OF SUPPLIERS
- 5.2.4 BARGAINING POWER OF BUYERS
- 5.2.5 INTENSITY OF COMPETITIVE RIVALRY
5.3 MACROECONOMIC INDICATORS
- 5.3.1 GLOBAL HEALTHCARE EXPENDITURE
- 5.3.2 REAL HOUSEHOLD INCOME
5.4 VALUE CHAIN ANALYSIS
- 5.4.1 RAW MATERIAL SOURCING
- 5.4.2 EXTRACTION & PROCESSING
- 5.4.3 INGREDIENT MANUFACTURING & STANDARDIZATION
- 5.4.4 QUALITY ASSURANCE, R&D & REGULATORY
- 5.4.5 COMMERCIALIZATION & DISTRIBUTION
- 5.4.6 INGREDIENT APPLICATION
5.5 ECOSYSTEM ANALYSIS
- 5.5.1 DEMAND SIDE
- 5.5.2 SUPPLY SIDE
5.6 PRICING ANALYSIS
- 5.6.1 INDICATIVE PRICE TREND AMONG MARKET PLAYERS
- 5.6.2 AVERAGE SELLING PRICE TREND, BY INGREDIENT TYPE
- 5.6.3 AVERAGE SELLING PRICE TREND, BY REGION
5.7 TRADE ANALYSIS
- 5.7.1 TRADE ANALYSIS OF HS CODE 2936: PROVITAMINS AND VITAMINS
  - 5.7.1.1 Export Trends of HS Code 2936 (2021-2025)
  - 5.7.1.2 Import Trends under HS Code 2936 (2021-2025)
5.8 KEY CONFERENCES & EVENTS
5.9 TRENDS IMPACTING CUSTOMERS' BUSINESSES
5.10 INVESTMENT AND FUNDING SCENARIO
5.11 CASE STUDY ANALYSIS
- 5.11.1 DSM-FIRMENICH SUPPORTED KOREA EUNDAN'S TRANSITION TO ALGAL OMEGA-3
- 5.11.2 KERRY - BC30 PROBIOTIC IN FUNCTIONAL HOT BEVERAGE
- 5.11.3 INGREDION - VITESSENCE PULSE 1853 PEA PROTEIN IN VEGAN BEVERAGE
5.12 IMPACT OF US TARIFF - NUTRACEUTICAL INGREDIENTS MARKET
- 5.12.1 INTRODUCTION
- 5.12.2 PRICE IMPACT ANALYSIS
- 5.12.3 IMPACT ON COUNTRY/REGION
  - 5.12.3.1 US
  - 5.12.3.2 Europe
  - 5.12.3.3 Asia Pacific
- 5.12.4 IMPACT ON END-USE INDUSTRIES

6 REGULATORY AND SUSTAINABILITY LANDSCAPE

6.1 INTRODUCTION
6.2 REGIONAL REGULATIONS AND COMPLIANCE
- 6.2.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
- 6.2.2 INDUSTRY STANDARDS
6.3 SUSTAINABILITY INITIATIVES
- 6.3.1 SUSTAINABLE AND RESPONSIBLE SOURCING
- 6.3.2 RESOURCE EFFICIENCY AND LOW-CARBON MANUFACTURING
- 6.3.3 CIRCULAR ECONOMY AND SUSTAINABLE PRODUCTION
- 6.3.4 CIRCULAR ECONOMY AND FOOD WASTE REDUCTION
6.4 IMPACT OF REGULATORY POLICIES ON SUSTAINABILITY INITIATIVES
6.5 CERTIFICATIONS, LABELING, ECO-STANDARDS

7 TECHNOLOGICAL ADVANCEMENTS, AI-DRIVEN IMPACT, PATENTS, INNOVATIONS, AND FUTURE APPLICATIONS

7.1 INTRODUCTION
7.2 KEY TECHNOLOGIES
- 7.2.1 ADVANCED EXTRACTION & PURIFICATION TECHNOLOGIES
- 7.2.2 PRECISION FERMENTATION & ADVANCED BIOPROCESSING
- 7.2.3 ENCAPSULATION & ADVANCED DELIVERY SYSTEMS
7.3 COMPLEMENTARY TECHNOLOGIES
- 7.3.1 ADVANCED ANALYTICAL & CHARACTERIZATION TECHNOLOGIES
- 7.3.2 NANOTECHNOLOGY & ADVANCED FORMULATION TECHNOLOGIES
- 7.3.3 AUTOMATION, PROCESS MONITORING & DIGITAL MANUFACTURING TECHNOLOGIES
7.4 ADJACENT TECHNOLOGIES
- 7.4.1 SYNTHETIC BIOLOGY & BIOINFORMATICS
- 7.4.2 PERSONALIZED NUTRITION & DIGITAL HEALTH TECHNOLOGIES
- 7.4.3 ADVANCED FOOD PROCESSING & 3D FOOD-PRINTING TECHNOLOGIES
7.5 TECHNOLOGY/PRODUCT ROADMAP
- 7.5.1 SHORT-TERM | OPTIMIZATION OF EXTRUSION PROCESSES AND CLEAN-LABEL PRODUCT DEVELOPMENT
- 7.5.2 MID-TERM | INTELLIGENT MANUFACTURING AND COMMERCIALIZATION OF NEXT-GENERATION PROTEIN INGREDIENTS
- 7.5.3 LONG-TERM | AUTONOMOUS AI-DRIVEN MANUFACTURING AND SUSTAINABLE PROTEIN INNOVATION
7.6 PATENT ANALYSIS
- 7.6.1 LIST OF MAJOR PATENTS
7.7 FUTURE APPLICATIONS
- 7.7.1 PERSONALIZED & PRECISION NUTRITION
- 7.7.2 FUNCTIONAL & SPECIALIZED NUTRITION PRODUCTS
7.8 IMPACT OF GENERATIVE AI ON NUTRACEUTICAL INGREDIENTS MARKET
- 7.8.1 INTRODUCTION
- 7.8.2 TOP USE CASES AND MARKET POTENTIAL
- 7.8.3 BEST PRACTICES IN NUTRACEUTICAL INGREDIENTS INDUSTRY
- 7.8.4 CASE STUDIES OF AI IMPLEMENTATION IN NUTRACEUTICAL INGREDIENTS MARKET
- 7.8.5 INTERCONNECTED ADJACENT ECOSYSTEM AND IMPACT ON MARKET PLAYERS
- 7.8.6 CLIENTS' READINESS TO ADOPT GENERATIVE AI IN NUTRACEUTICAL INGREDIENTS MARKET
7.9 SUCCESS STORIES AND REAL-WORLD APPLICATIONS

8 CUSTOMER LANDSCAPE AND BUYER BEHAVIOR

8.1 INTRODUCTION
8.2 DECISION-MAKING PROCESS
8.3 BUYER STAKEHOLDERS AND BUYING EVALUATION CRITERIA
- 8.3.1 KEY STAKEHOLDERS IN BUYING PROCESS
- 8.3.2 BUYING CRITERIA
8.4 ADOPTION BARRIERS AND INTERNAL CHALLENGES
8.5 UNMET NEEDS OF VARIOUS END-USE INDUSTRIES
8.6 MARKET PROFITABILITY

9 NUTRACEUTICAL INGREDIENTS MARKET, BY FUNCTION

9.1 INTRODUCTION
9.2 NUTRITIONAL SUPPORT
9.3 DIGESTIVE HEALTH
9.4 IMMUNE HEALTH
9.5 CARDIOVASCULAR HEALTH
9.6 BONE & JOINT HEALTH
9.7 COGNITIVE & MENTAL HEALTH
9.8 SPORTS & PERFORMANCE
9.9 WEIGHT MANAGEMENT
9.10 OTHERS (BEAUTY & HEALTHY AGING, ETC.)

10 NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE

10.1 INTRODUCTION
10.2 FUNCTIONAL PROTEINS
- 10.2.1 NUTRITIONAL FUNCTIONALITY AND EXPANDING APPLICATIONS
10.3 OMEGA-3 FATTY ACIDS
- 10.3.1 GROWING DEMAND FOR CARDIOVASCULAR, COGNITIVE, AND PREVENTIVE NUTRITION
10.4 PROBIOTICS
- 10.4.1 EXPANDING APPLICATIONS IN GUT HEALTH AND FUNCTIONAL NUTRITION
10.5 PREBIOTICS
- 10.5.1 SUPPORTING GUT MICROBIOME HEALTH AND FUNCTIONAL NUTRITION
10.6 FIBERS & SPECIALTY CARBOHYDRATES
- 10.6.1 EXPANDING ROLE IN DIGESTIVE HEALTH AND PRODUCT FORMULATION
10.7 VITAMINS
- 10.7.1 ESSENTIAL MICRONUTRIENTS SUPPORTING PREVENTIVE AND SPECIALIZED NUTRITION
- 10.7.2 VITAMIN A
- 10.7.3 VITAMIN B
- 10.7.4 VITAMIN C
- 10.7.5 VITAMIN D
- 10.7.6 VITAMIN E
- 10.7.7 OTHER VITAMINS (MULTIVITAMIN, ETC.)
10.8 MINERALS
- 10.8.1 ESSENTIAL MICRONUTRIENTS ACROSS SUPPLEMENTATION, FORTIFICATION, AND SPECIALIZED NUTRITION
- 10.8.2 CALCIUM
- 10.8.3 MAGNESIUM
- 10.8.4 IRON
- 10.8.5 ZINC
- 10.8.6 OTHER MINERALS
10.9 AMINO ACIDS
- 10.9.1 EXPANDING ROLE IN TARGETED NUTRITION, SPORTS PERFORMANCE, AND METABOLIC SUPPORT
- 10.9.2 BRANCHED-CHAIN AMINO ACIDS
- 10.9.3 ESSENTIAL AMINO ACIDS
- 10.9.4 NON-ESSENTIAL AMINO ACIDS
- 10.9.5 SPECIALTY AMINO ACIDS
10.10 CAROTENOIDS
- 10.10.1 NATURAL PIGMENTS WITH EXPANDING NUTRITIONAL AND FUNCTIONAL APPLICATIONS
10.11 OTHER INGREDIENT TYPES

11 NUTRACEUTICAL INGREDIENTS MARKET, BY SOURCE

11.1 INTRODUCTION
11.2 PLANT-BASED
- 11.2.1 EXPANSION OF PLANT-BASED SUPPLY AND PROCESSING CAPACITY TO DRIVE NUTRACEUTICAL INGREDIENT MARKET GROWTH
11.3 ANIMAL-BASED
- 11.3.1 GROWING DEMAND FOR HIGH-PROTEIN AND BIOACTIVE INGREDIENTS TO DRIVE ANIMAL-BASED INGREDIENT GROWTH
11.4 MICROBIAL-BASED
- 11.4.1 EXPANSION OF MICROBIAL-DERIVED INGREDIENTS AND FERMENTATION-BASED PRODUCTION TO DRIVE MARKET GROWTH
11.5 SYNTHETICS
- 11.5.1 CONSISTENT QUALITY AND SCALABLE PRODUCTION OF SYNTHETIC INGREDIENTS TO SUPPORT MARKET GROWTH

12 NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION

12.1 INTRODUCTION
12.2 HUMAN NUTRITION
- 12.2.1 DIETARY SUPPLEMENTS
  - 12.2.1.1 Dietary supplements remain largest application for nutraceutical ingredients due to their established consumer acceptance
- 12.2.2 FUNCTIONAL FOODS
  - 12.2.2.1 Growing health-conscious consumption is driving nutraceutical ingredient adoption in functional foods
- 12.2.3 FUNCTIONAL BEVERAGES
  - 12.2.3.1 Demand for convenient wellness products is accelerating nutraceutical ingredient use in beverages
- 12.2.4 MEDICAL & SPECIALIZED NUTRITION
  - 12.2.4.1 Rising demand for targeted nutrition is supporting use of specialty nutraceutical ingredients
- 12.2.5 INFANT & EARLY-LIFE NUTRITION
  - 12.2.5.1 Greater focus on early-life health is driving demand for high-quality nutraceutical ingredients
12.3 ANIMAL NUTRITION
- 12.3.1 COMPANION ANIMAL NUTRITION
  - 12.3.1.1 Pet humanization is accelerating demand for nutraceutical ingredients in companion animal nutrition
- 12.3.2 LIVESTOCK NUTRITION
  - 12.3.2.1 Reduced reliance on antibiotics is driving nutraceutical adoption in livestock nutrition
- 12.3.3 AQUACULTURE NUTRITION
  - 12.3.3.1 Growing aquaculture production is increasing demand for functional nutrition ingredients
- 12.3.4 OTHER ANIMAL NUTRITION
  - 12.3.4.1 Specialized animal health needs are creating demand for targeted nutraceutical ingredients

13 NUTRACEUTICAL INGREDIENTS MARKET, BY REGION

13.1 INTRODUCTION
13.2 NORTH AMERICA
- 13.2.1 US
  - 13.2.1.1 Strong supplement penetration and rising demand for functional nutrition
- 13.2.2 CANADA
  - 13.2.2.1 Growing demand for natural products supports market expansion
- 13.2.3 MEXICO
  - 13.2.3.1 Expanding preventive nutrition demand and broadening supplement ecosystem
13.3 EUROPE
- 13.3.1 GERMANY
  - 13.3.1.1 High food supplement penetration and demand for micronutrients support market growth
- 13.3.2 UK
  - 13.3.2.1 Established food supplement use and regulatory support for innovative ingredients support market growth
- 13.3.3 FRANCE
  - 13.3.3.1 Established supplement market and growing demand for targeted nutrition support market growth
- 13.3.4 ITALY
  - 13.3.4.1 Large supplement product base and broad use of nutritional ingredients support market growth
- 13.3.5 SPAIN
  - 13.3.5.1 Established supplement regulation and broad nutritional ingredient applications support market growth
- 13.3.6 REST OF EUROPE
  - 13.3.6.1 Expanding food supplement use and regulatory harmonization support market opportunities
13.4 ASIA PACIFIC
- 13.4.1 CHINA
  - 13.4.1.1 Expanding health food formulation and diversification of nutritional products support market growth
- 13.4.2 INDIA
  - 13.4.2.1 Large agricultural base and expanding nutraceutical ecosystem support market growth
- 13.4.3 JAPAN
  - 13.4.3.1 Rapid population aging and preventive healthcare culture drive demand for functional ingredients
- 13.4.4 AUSTRALIA & NEW ZEALAND
  - 13.4.4.1 Strong supplement adoption and export-oriented health product ecosystem support nutraceutical ingredient demand
- 13.4.5 REST OF ASIA PACIFIC
13.5 SOUTH AMERICA
- 13.5.1 BRAZIL
  - 13.5.1.1 Strong supplement penetration and rapid expansion of protein and vitamin ingredients
- 13.5.2 ARGENTINA
  - 13.5.2.1 Growing demand for targeted nutrition and specialty nutraceutical ingredients
- 13.5.3 REST OF SOUTH AMERICA
  - 13.5.3.1 Emerging consumer awareness and diversification of functional nutrition
13.6 REST OF THE WORLD (ROW)
- 13.6.1 MIDDLE EAST
  - 13.6.1.1 Rising nutrition-related health needs and preventive healthcare focus
- 13.6.2 AFRICA
  - 13.6.2.1 Nutritional needs and food fortification programs create structural ingredient demand

14 COMPETITIVE LANDSCAPE

14.1 OVERVIEW
14.2 KEY PLAYER STRATEGIES/RIGHT TO WIN, 2021-2026
14.3 BRAND/PRODUCT COMPARISON
- 14.3.1 CARGILL, INCORPORATED (EPICOR)
- 14.3.2 ADM (FIBERSOL)
- 14.3.3 GLANBIA PLC (FERRIUP)
- 14.3.4 DSM-FIRMENICH (PEPTOPRO)
- 14.3.5 ROQUETTE FRERES (NUTRALYS)
14.4 REVENUE ANALYSIS, 2023-2025
14.5 COMPANY VALUATION AND FINANCIAL METRICS
- 14.5.1 COMPANY VALUATION
- 14.5.2 EV/EBITDA
14.6 MARKET SHARE ANALYSIS, 2025
14.7 NUTRACEUTICAL INGREDIENTS MARKET COMPANY EVALUATION MATRIX: KEY PLAYERS, 2025
- 14.7.1 STARS
- 14.7.2 EMERGING LEADERS
- 14.7.3 PERVASIVE PLAYERS
- 14.7.4 PARTICIPANTS
- 14.7.5 COMPANY FOOTPRINT: KEY PLAYERS, 2025
  - 14.7.5.1 Company footprint
  - 14.7.5.2 Region footprint
  - 14.7.5.3 Ingredient type footprint
  - 14.7.5.4 Source footprint
  - 14.7.5.5 Application footprint
14.8 COMPANY EVALUATION MATRIX: START-UPS/SMES, 2025
- 14.8.1 PROGRESSIVE COMPANIES
- 14.8.2 RESPONSIVE COMPANIES
- 14.8.3 DYNAMIC COMPANIES
- 14.8.4 STARTING BLOCKS
- 14.8.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2025
  - 14.8.5.1 Key startups/SMEs
  - 14.8.5.2 Competitive benchmarking of key startups/SMEs
14.9 COMPETITIVE SCENARIO
- 14.9.1 PRODUCT LAUNCHES
- 14.9.2 DEALS
- 14.9.3 EXPANSIONS

15 COMPANY PROFILES

15.1 KEY PLAYERS
- 15.1.1 CARGILL, INCORPORATED
  - 15.1.1.1 Business overview
  - 15.1.1.2 Products offered
  - 15.1.1.3 Recent developments
    - 15.1.1.3.1 Product launches
    - 15.1.1.3.2 Deals
    - 15.1.1.3.3 Expansions
    - 15.1.1.3.4 Other developments
  - 15.1.1.4 MnM view
    - 15.1.1.4.1 Right to win
    - 15.1.1.4.2 Strategic choices
    - 15.1.1.4.3 Weaknesses and competitive threats
- 15.1.2 ADM
  - 15.1.2.1 Business overview
  - 15.1.2.2 Products offered
  - 15.1.2.3 Recent developments
    - 15.1.2.3.1 Product launches
    - 15.1.2.3.2 Deals
    - 15.1.2.3.3 Expansions
    - 15.1.2.3.4 Other developments
  - 15.1.2.4 MnM view
    - 15.1.2.4.1 Right to win
    - 15.1.2.4.2 Strategic choices
    - 15.1.2.4.3 Weaknesses and competitive threats
- 15.1.3 INTERNATIONAL FLAVORS & FRAGRANCES INC.
  - 15.1.3.1 Business overview
  - 15.1.3.2 Products offered
  - 15.1.3.3 Recent developments
    - 15.1.3.3.1 Product launches
    - 15.1.3.3.2 Deals
    - 15.1.3.3.3 Expansions
    - 15.1.3.3.4 Other developments
  - 15.1.3.4 MnM view
    - 15.1.3.4.1 Right to win
    - 15.1.3.4.2 Strategic choices
    - 15.1.3.4.3 Weaknesses and competitive threats
- 15.1.4 BASF
  - 15.1.4.1 Business overview
  - 15.1.4.2 Products offered
  - 15.1.4.3 Recent developments
    - 15.1.4.3.1 Product launches
    - 15.1.4.3.2 Deals
    - 15.1.4.3.3 Expansions
    - 15.1.4.3.4 Other developments
  - 15.1.4.4 MnM view
    - 15.1.4.4.1 Right to win
    - 15.1.4.4.2 Strategic choices
    - 15.1.4.4.3 Weaknesses and competitive threats
- 15.1.5 GLANBIA PLC
  - 15.1.5.1 Business overview
  - 15.1.5.2 Products offered
  - 15.1.5.3 Recent developments
    - 15.1.5.3.1 Product launches
    - 15.1.5.3.2 Deals
    - 15.1.5.3.3 Expansions
    - 15.1.5.3.4 Other developments
  - 15.1.5.4 MnM view
    - 15.1.5.4.1 Right to win
    - 15.1.5.4.2 Strategic choices
    - 15.1.5.4.3 Weaknesses and competitive threats
- 15.1.6 ARLA FOODS AMBA
  - 15.1.6.1 Business overview
  - 15.1.6.2 Products offered
  - 15.1.6.3 Recent developments
    - 15.1.6.3.1 Product launches
    - 15.1.6.3.2 Deals
    - 15.1.6.3.3 Expansions
    - 15.1.6.3.4 Other developments
  - 15.1.6.4 MnM view
- 15.1.7 DSM-FIRMENICH
  - 15.1.7.1 Business overview
  - 15.1.7.2 Products offered
  - 15.1.7.3 Recent developments
    - 15.1.7.3.1 Product launches
    - 15.1.7.3.2 Deals
    - 15.1.7.3.3 Expansions
    - 15.1.7.3.4 Other developments
  - 15.1.7.4 MnM view
- 15.1.8 INGREDION
  - 15.1.8.1 Business overview
  - 15.1.8.2 Products offered
  - 15.1.8.3 Recent developments
    - 15.1.8.3.1 Product launches
    - 15.1.8.3.2 Deals
    - 15.1.8.3.3 Expansions
    - 15.1.8.3.4 Other developments
  - 15.1.8.4 MnM view
- 15.1.9 TATE & LYLE
  - 15.1.9.1 Business overview
  - 15.1.9.2 Recent developments
    - 15.1.9.2.1 Product launches
    - 15.1.9.2.2 Deals
    - 15.1.9.2.3 Expansions
    - 15.1.9.2.4 Other developments
  - 15.1.9.3 MnM view
- 15.1.10 ROQUETTE FRERES
  - 15.1.10.1 Business overview
  - 15.1.10.2 Products offered
  - 15.1.10.3 Recent developments
    - 15.1.10.3.1 Product launches
    - 15.1.10.3.2 Deals
    - 15.1.10.3.3 Expansions
    - 15.1.10.3.4 Other developments
  - 15.1.10.4 MnM view
- 15.1.11 ASSOCIATED BRITISH FOODS PLC
  - 15.1.11.1 Business overview
  - 15.1.11.2 Products offered
  - 15.1.11.3 Recent developments
    - 15.1.11.3.1 Product launches
    - 15.1.11.3.2 Deals
    - 15.1.11.3.3 Expansions
    - 15.1.11.3.4 Other developments
  - 15.1.11.4 MnM view
- 15.1.12 FONTERRA CO-OPERATIVE GROUP LIMITED
  - 15.1.12.1 Business overview
  - 15.1.12.2 Products offered
  - 15.1.12.3 Recent developments
    - 15.1.12.3.1 Product launches
    - 15.1.12.3.2 Deals
    - 15.1.12.3.3 Expansions
    - 15.1.12.3.4 Other developments
  - 15.1.12.4 MnM view
- 15.1.13 KERRY GROUP PLC
  - 15.1.13.1 Business overview
  - 15.1.13.2 Products offered
  - 15.1.13.3 Recent developments
    - 15.1.13.3.1 Product launches
    - 15.1.13.3.2 Deals
    - 15.1.13.3.3 Expansions
    - 15.1.13.3.4 Other developments
  - 15.1.13.4 MnM view
- 15.1.14 NOVONESIS GROUP
  - 15.1.14.1 Business overview
  - 15.1.14.2 Products offered
  - 15.1.14.3 Recent developments
    - 15.1.14.3.1 Product launches
    - 15.1.14.3.2 Deals
    - 15.1.14.3.3 Expansions
    - 15.1.14.3.4 Other developments
  - 15.1.14.4 MnM view
- 15.1.15 BALCHEM CORP.
  - 15.1.15.1 Business overview
  - 15.1.15.2 Products offered
  - 15.1.15.3 Recent developments
    - 15.1.15.3.1 Product launches
    - 15.1.15.3.2 Deals
    - 15.1.15.3.3 Expansions
    - 15.1.15.3.4 Other developments
  - 15.1.15.4 MnM view
15.2 OTHER PLAYERS
- 15.2.1 AJINOMOTO CO., INC.
  - 15.2.1.1 Business overview
  - 15.2.1.2 Products offered
  - 15.2.1.3 Recent developments
    - 15.2.1.3.1 Deals
    - 15.2.1.3.2 Expansions
    - 15.2.1.3.3 Other developments
  - 15.2.1.4 MnM view
- 15.2.2 DIVI'S LABORATORIES LIMITED
  - 15.2.2.1 Business overview
  - 15.2.2.2 Products offered
  - 15.2.2.3 Recent developments
    - 15.2.2.3.1 Deals
    - 15.2.2.3.2 Expansions
  - 15.2.2.4 MnM view
- 15.2.3 KEMIN INDUSTRIES, INC.
  - 15.2.3.1 Business overview
  - 15.2.3.2 Products offered
  - 15.2.3.3 Recent developments
    - 15.2.3.3.1 Product launches
    - 15.2.3.3.2 Deals
    - 15.2.3.3.3 Other developments
  - 15.2.3.4 MnM view
- 15.2.4 GELITA
  - 15.2.4.1 Business overview
  - 15.2.4.2 Products offered
  - 15.2.4.3 Recent developments
    - 15.2.4.3.1 Product launches
    - 15.2.4.3.2 Deals
    - 15.2.4.3.3 Expansions
    - 15.2.4.3.4 Other developments
  - 15.2.4.4 MnM view
- 15.2.5 BENEO
  - 15.2.5.1 Business overview
  - 15.2.5.2 Products offered
  - 15.2.5.3 Recent developments
    - 15.2.5.3.1 Product launches
    - 15.2.5.3.2 Deals
    - 15.2.5.3.3 Expansions
    - 15.2.5.3.4 Other developments
  - 15.2.5.4 MnM view
- 15.2.6 COSUCRA
- 15.2.7 CONAGEN, INC.
- 15.2.8 SARSHIKA PHARMACHEM LLP
- 15.2.9 CANURTA NATURALS USA
- 15.2.10 EVANIUM

16 RESEARCH METHODOLOGY

16.1 RESEARCH DATA
- 16.1.1 SECONDARY DATA
  - 16.1.1.1 List of major secondary sources
  - 16.1.1.2 Key data from secondary sources
- 16.1.2 PRIMARY DATA
  - 16.1.2.1 Key data from primary sources
  - 16.1.2.2 Key industry insights
  - 16.1.2.3 Breakdown of primaries
16.2 MARKET SIZE ESTIMATION
- 16.2.1 BOTTOM-UP APPROACH
- 16.2.2 TOP-DOWN APPROACH
  - 16.2.2.1 Approach to estimate market size using top-down analysis
- 16.2.3 SUPPLY-SIDE ANALYSIS
- 16.2.4 DEMAND-SIDE ANALYSIS
16.3 DATA TRIANGULATION
16.4 RESEARCH ASSUMPTIONS
16.5 RESEARCH LIMITATIONS AND RISK ASSESSMENT

17 ADJACENT & RELATED MARKETS

17.1 INTRODUCTION
17.2 LIMITATIONS
17.3 PROTEIN INGREDIENTS MARKET
- 17.3.1 MARKET DEFINITION
- 17.3.2 MARKET OVERVIEW
17.4 NUTRACEUTICAL GUMMIES MARKET
- 17.4.1 MARKET DEFINITION
- 17.4.2 MARKET OVERVIEW

18 APPENDIX

18.1 DISCUSSION GUIDE
18.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
18.3 CUSTOMIZATION OPTIONS
18.4 RELATED REPORTS
18.5 AUTHOR DETAILS

Product Code: FB 2211

List of Tables

TABLE 1 USD EXCHANGE RATES, 2021-2025
TABLE 2 NUTRACEUTICAL INGREDIENTS MARKET: PORTER'S FIVE FORCES ANALYSIS
TABLE 3 NUTRACEUTICAL INGREDIENTS MARKET: SUPPLY CHAIN (ECOSYSTEM)
TABLE 4 AVERAGE SELLING PRICE (ASP), BY INGREDIENT TYPE, 2022-2025 (USD/KG)
TABLE 5 AVERAGE SELLING PRICE (ASP), BY REGION, 2022-2025 (USD/KG)
TABLE 6 TOP 10 EXPORTERS OF HS CODE 2936, 2021-2025 (USD MILLION)
TABLE 7 TOP 10 EXPORTERS OF HS CODE 2936, 2021-2025 (K TONS)
TABLE 8 TOP 10 EXPORTERS OF HS CODE 2936, 2021-2025 (USD MILLION)
TABLE 9 TOP 10 IMPORTERS OF HS CODE 2936, 2021-2025 (K TONS)
TABLE 10 NUTRACEUTICAL INGREDIENTS MARKET: DETAILED LIST OF CONFERENCES & EVENTS, 2026-2027
TABLE 11 TARIFF IMPACT ON END-USE INDUSTRIES: NUTRACEUTICAL INGREDIENTS MARKET
TABLE 16 INTERNATIONAL: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 17 GLOBAL INDUSTRY STANDARDS IN NUTRACEUTICAL INGREDIENTS MARKET
TABLE 18 SUSTAINABILITY INITIATIVES IN NUTRACEUTICAL INGREDIENTS MARKET
TABLE 19 IMPACT OF REGULATORY POLICIES ON SUSTAINABILITY INITIATIVES
TABLE 20 CERTIFICATION FOR NUTRACEUTICAL INGREDIENTS MARKET
TABLE 21 LABELING FOR NUTRACEUTICAL INGREDIENTS MARKET
TABLE 22 ECO-STANDARDS FOR NUTRACEUTICAL INGREDIENTS MARKET
TABLE 23 LIST OF MAJOR PATENTS IN NUTRACEUTICAL INGREDIENTS MARKET, 2021-2026
TABLE 24 TOP USE CASES AND MARKET POTENTIAL
TABLE 25 BEST PRACTICES: COMPANIES IMPLEMENTING USE CASES
TABLE 26 NUTRACEUTICAL INGREDIENTS MARKET: CASE STUDIES RELATED TO GEN AI IMPLEMENTATION
TABLE 27 INTERCONNECTED ADJACENT ECOSYSTEM AND IMPACT ON MARKET PLAYERS
TABLE 28 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY APPLICATION
TABLE 29 KEY BUYING CRITERIA, BY APPLICATION
TABLE 30 UNMET NEEDS IN NUTRACEUTICAL INGREDIENTS MARKET, BY END-USE INDUSTRY
TABLE 31 NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE, 2022-2025 (USD MILLION)
TABLE 32 NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE, 2026-2031 (USD MILLION)
TABLE 33 NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE, 2022-2025 (TONS)
TABLE 34 NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE, 2026-2031 (TONS)
TABLE 35 FUNCTIONAL PROTEINS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2022-2025 (USD MILLION)
TABLE 36 FUNCTIONAL PROTEINS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2026-2031 (USD MILLION)
TABLE 37 FUNCTIONAL PROTEINS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2022-2025 (TONS)
TABLE 38 FUNCTIONAL PROTEINS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2026-2031 (TONS)
TABLE 39 OMEGA-3 FATTY ACIDS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2022-2025 (USD MILLION)
TABLE 40 OMEGA-3 FATTY ACIDS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2026-2031 (USD MILLION)
TABLE 41 OMEGA-3 FATTY ACIDS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2022-2025 (TONS)
TABLE 42 OMEGA-3 FATTY ACIDS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2026-2031 (TONS)
TABLE 43 PROBIOTICS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2022-2025 (USD MILLION)
TABLE 44 PROBIOTICS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2026-2031 (USD MILLION)
TABLE 45 PROBIOTICS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2022-2025 (TONS)
TABLE 46 PROBIOTICS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2026-2031 (TONS)
TABLE 47 PREBIOTICS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2022-2025 (USD MILLION)
TABLE 48 PREBIOTICS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2026-2031 (USD MILLION)
TABLE 49 PREBIOTICS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2022-2025 (TONS)
TABLE 50 PREBIOTICS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2026-2031 (TONS)
TABLE 51 FIBERS & SPECIALTY CARBOHYDRATES: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2022-2025 (USD MILLION)
TABLE 52 FIBERS & SPECIALTY CARBOHYDRATES: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2026-2031 (USD MILLION)
TABLE 53 FIBERS & SPECIALTY CARBOHYDRATES: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2022-2025 (TONS)
TABLE 54 FIBERS & SPECIALTY CARBOHYDRATES: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2026-2031 (TONS)
TABLE 55 VITAMINS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2022-2025 (USD MILLION)
TABLE 56 VITAMINS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2026-2031 (USD MILLION)
TABLE 57 VITAMINS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2022-2025 (TONS)
TABLE 58 VITAMINS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2026-2031 (TONS)
TABLE 59 VITAMINS: NUTRACEUTICAL INGREDIENTS MARKET, BY SUBTYPE, 2022-2025 (USD MILLION)
TABLE 60 VITAMINS: NUTRACEUTICAL INGREDIENTS MARKET, BY SUBTYPE, 2026-2031 (USD MILLION)
TABLE 61 VITAMIN A: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2022-2025 (USD MILLION)
TABLE 62 VITAMIN A: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2026-2031 (USD MILLION)
TABLE 63 VITAMIN B: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2022-2025 (USD MILLION)
TABLE 64 VITAMIN B: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2026-2031 (USD MILLION)
TABLE 65 VITAMIN C: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2022-2025 (USD MILLION)
TABLE 66 VITAMIN C: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2026-2031 (USD MILLION)
TABLE 67 VITAMIN D: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2022-2025 (USD MILLION)
TABLE 68 VITAMIN D: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2026-2031 (USD MILLION)
TABLE 69 VITAMIN E: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2022-2025 (USD MILLION)
TABLE 70 VITAMIN E: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2026-2031 (USD MILLION)
TABLE 71 OTHER VITAMINS (MULTIVITAMIN, ETC.): NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2022-2025 (USD MILLION)
TABLE 72 OTHER VITAMINS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2026-2031 (USD MILLION)
TABLE 73 MINERALS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2022-2025 (USD MILLION)
TABLE 74 MINERALS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2026-2031 (USD MILLION)
TABLE 75 MINERALS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2022-2025 (TONS)
TABLE 76 MINERALS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2026-2031 (TONS)
TABLE 77 MINERALS: NUTRACEUTICAL INGREDIENTS MARKET, BY SUBTYPE, 2022-2025 (USD MILLION)
TABLE 78 MINERALS: NUTRACEUTICAL INGREDIENTS MARKET, BY SUBTYPE, 2026-2031 (USD MILLION)
TABLE 79 CALCIUM: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2022-2025 (USD MILLION)
TABLE 80 CALCIUM: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2026-2031 (USD MILLION)
TABLE 81 MAGNESIUM: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2022-2025 (USD MILLION)
TABLE 82 MAGNESIUM: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2026-2031 (USD MILLION)
TABLE 83 IRON: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2022-2025 (USD MILLION)
TABLE 84 IRON: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2026-2031 (USD MILLION)
TABLE 85 ZINC: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2022-2025 (USD MILLION)
TABLE 86 ZINC: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2026-2031 (USD MILLION)
TABLE 87 OTHER MINERALS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2022-2025 (USD MILLION)
TABLE 88 OTHER MINERALS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2026-2031 (USD MILLION)
TABLE 89 AMINO ACIDS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2022-2025 (USD MILLION)
TABLE 90 AMINO ACIDS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2026-2031 (USD MILLION)
TABLE 91 AMINO ACIDS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2022-2025 (TONS)
TABLE 92 AMINO ACIDS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2026-2031 (TONS)
TABLE 93 AMINO ACIDS: NUTRACEUTICAL INGREDIENTS MARKET, BY SUBTYPE, 2022-2025 (USD MILLION)
TABLE 94 AMINO ACIDS: NUTRACEUTICAL INGREDIENTS MARKET, BY SUBTYPE, 2026-2031 (USD MILLION)
TABLE 95 BRANCHED-CHAIN AMINO ACIDS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2022-2025 (USD MILLION)
TABLE 96 BRANCHED-CHAIN AMINO ACIDS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2026-2031 (USD MILLION)
TABLE 97 ESSENTIAL AMINO ACIDS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2022-2025 (USD MILLION)
TABLE 98 ESSENTIAL AMINO ACIDS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2026-2031 (USD MILLION)
TABLE 99 NON-ESSENTIAL AMINO ACIDS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2022-2025 (USD MILLION)
TABLE 100 NON-ESSENTIAL AMINO ACIDS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2026-2031 (USD MILLION)
TABLE 101 SPECIALTY AMINO ACIDS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2022-2025 (USD MILLION)
TABLE 102 SPECIALTY AMINO ACIDS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2026-2031 (USD MILLION)
TABLE 103 CAROTENOIDS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2022-2025 (USD MILLION)
TABLE 104 CAROTENOIDS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2026-2031 (USD MILLION)
TABLE 105 CAROTENOIDS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2022-2025 (TONS)
TABLE 106 CAROTENOIDS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2026-2031 (TONS)
TABLE 107 OTHER INGREDIENT TYPES: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2022-2025 (USD MILLION)
TABLE 108 OTHER INGREDIENT TYPES: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2026-2031 (USD MILLION)
TABLE 109 OTHER INGREDIENT TYPES: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2022-2025 (TONS)
TABLE 110 OTHER INGREDIENT TYPES: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2026-2031 (TONS)
TABLE 111 NUTRACEUTICAL INGREDIENTS MARKET, BY SOURCE, 2022-2025 (USD MILLION)
TABLE 112 NUTRACEUTICAL INGREDIENTS MARKET, BY SOURCE, 2026-2031 (USD MILLION)
TABLE 113 PLANT-BASED: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2022-2025 (USD MILLION)
TABLE 114 PLANT-BASED: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2026-2031 (USD MILLION)
TABLE 115 ANIMAL-BASED: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2022-2025 (USD MILLION)
TABLE 116 ANIMAL-BASED: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2026-2031 (USD MILLION)
TABLE 117 MICROBIAL-BASED: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2022-2025 (USD MILLION)
TABLE 118 MICROBIAL-BASED: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2026-2031 (USD MILLION)
TABLE 119 SYNTHETICS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2022-2025 (USD MILLION)
TABLE 120 SYNTHETICS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2026-2031 (USD MILLION)
TABLE 121 NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2022-2025 (USD MILLION)
TABLE 122 NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2026-2031 (USD MILLION)
TABLE 123 HUMAN NUTRITION: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2022-2025 (USD MILLION)
TABLE 124 HUMAN NUTRITION: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2026-2031 (USD MILLION)
TABLE 125 HUMAN NUTRITION: NUTRACEUTICAL INGREDIENTS MARKET, BY SUBTYPE, 2022-2025 (USD MILLION)
TABLE 126 HUMAN NUTRITION: NUTRACEUTICAL INGREDIENTS MARKET, BY SUBTYPE, 2026-2031 (USD MILLION)
TABLE 127 DIETARY SUPPLEMENTS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2022-2025 (USD MILLION)
TABLE 128 DIETARY SUPPLEMENTS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2026-2031 (USD MILLION)
TABLE 129 FUNCTIONAL FOODS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2022-2025 (USD MILLION)
TABLE 130 FUNCTIONAL FOODS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2026-2031 (USD MILLION)
TABLE 131 FUNCTIONAL BEVERAGES: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2022-2025 (USD MILLION)
TABLE 132 FUNCTIONAL BEVERAGES: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2026-2031 (USD MILLION)
TABLE 133 MEDICAL & SPECIALIZED NUTRITION: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2022-2025 (USD MILLION)
TABLE 134 MEDICAL & SPECIALIZED NUTRITION: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2026-2031 (USD MILLION)
TABLE 135 INFANT & EARLY-LIFE NUTRITION: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2022-2025 (USD MILLION)
TABLE 136 INFANT & EARLY-LIFE NUTRITION: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2026-2031 (USD MILLION)
TABLE 137 ANIMAL NUTRITION: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2022-2025 (USD MILLION)
TABLE 138 ANIMAL NUTRITION: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2026-2031 (USD MILLION)
TABLE 139 ANIMAL NUTRITION: NUTRACEUTICAL INGREDIENTS MARKET, BY SUBTYPE, 2022-2025 (USD MILLION)
TABLE 140 ANIMAL NUTRITION: NUTRACEUTICAL INGREDIENTS MARKET, BY SUBTYPE, 2026-2031 (USD MILLION)
TABLE 141 COMPANION ANIMAL NUTRITION: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2022-2025 (USD MILLION)
TABLE 142 COMPANION ANIMAL NUTRITION: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2026-2031 (USD MILLION)
TABLE 143 LIVESTOCK NUTRITION: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2022-2025 (USD MILLION)
TABLE 144 LIVESTOCK NUTRITION: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2026-2031 (USD MILLION)
TABLE 145 AQUACULTURE NUTRITION: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2022-2025 (USD MILLION)
TABLE 146 AQUACULTURE NUTRITION: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2026-2031 (USD MILLION)
TABLE 147 OTHER ANIMAL NUTRITION: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2022-2025 (USD MILLION)
TABLE 148 OTHER ANIMAL NUTRITION: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2026-2031 (USD MILLION)
TABLE 149 NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2022-2025 (USD MILLION)
TABLE 150 NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2026-2031 (USD MILLION)
TABLE 151 NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2022-2025 (TONS)
TABLE 152 NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2026-2031 (TONS)
TABLE 153 NORTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY COUNTRY, 2022-2025 (USD MILLION)
TABLE 154 NORTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY COUNTRY, 2026-2031 (USD MILLION)
TABLE 155 NORTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY COUNTRY, 2022-2025 (TONS)
TABLE 156 NORTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY COUNTRY, 2026-2031 (TONS)
TABLE 157 NORTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE, 2022-2025 (USD MILLION)
TABLE 158 NORTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE, 2026-2031 (USD MILLION)
TABLE 159 NORTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE, 2022-2025 (TONS)
TABLE 160 NORTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE, 2026-2031 (TONS)
TABLE 161 NORTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY VITAMIN, 2022-2025 (USD MILLION)
TABLE 162 NORTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY VITAMIN, 2026-2031 (USD MILLION)
TABLE 163 NORTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY MINERAL, 2022-2025 (USD MILLION)
TABLE 164 NORTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY MINERAL, 2026-2031 (USD MILLION)
TABLE 165 NORTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY AMINO ACID, 2022-2025 (USD MILLION)
TABLE 166 NORTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY AMINO ACID, 2026-2031 (USD MILLION)
TABLE 167 NORTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY SOURCE, 2022-2025 (USD MILLION)
TABLE 168 NORTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY SOURCE, 2026-2031 (USD MILLION)
TABLE 169 NORTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2022-2025 (USD MILLION)
TABLE 170 NORTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2026-2031 (USD MILLION)
TABLE 171 NORTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY HUMAN NUTRITION, 2022-2025 (USD MILLION)
TABLE 172 NORTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY HUMAN NUTRITION, 2026-2031 (USD MILLION)
TABLE 173 NORTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY ANIMAL NUTRITION, 2022-2025 (USD MILLION)
TABLE 174 NORTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY ANIMAL NUTRITION, 2026-2031 (USD MILLION)
TABLE 175 US: NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE, 2022-2025 (USD MILLION)
TABLE 176 US: NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE, 2026-2031 (USD MILLION)
TABLE 177 US: NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE, 2022-2025 (TONS)
TABLE 178 US: NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE, 2026-2031 (TONS)
TABLE 179 US: NUTRACEUTICAL INGREDIENTS MARKET, BY VITAMIN, 2022-2025 (USD MILLION)
TABLE 180 US: NUTRACEUTICAL INGREDIENTS MARKET, BY VITAMIN, 2026-2031 (USD MILLION)
TABLE 181 US: NUTRACEUTICAL INGREDIENTS MARKET, BY MINERAL, 2022-2025 (USD MILLION)
TABLE 182 US: NUTRACEUTICAL INGREDIENTS MARKET, BY MINERAL, 2026-2031 (USD MILLION)
TABLE 183 US: NUTRACEUTICAL INGREDIENTS MARKET, BY AMINO ACID, 2022-2025 (USD MILLION)
TABLE 184 US: NUTRACEUTICAL INGREDIENTS MARKET, BY AMINO ACID, 2026-2031 (USD MILLION)
TABLE 185 US: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2022-2025 (USD MILLION)
TABLE 186 US: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2026-2031 (USD MILLION)
TABLE 187 US: NUTRACEUTICAL INGREDIENTS MARKET, BY HUMAN NUTRITION, 2022-2025 (USD MILLION)
TABLE 188 US: NUTRACEUTICAL INGREDIENTS MARKET, BY HUMAN NUTRITION, 2026-2031 (USD MILLION)
TABLE 189 US: NUTRACEUTICAL INGREDIENTS MARKET, BY ANIMAL NUTRITION, 2022-2025 (USD MILLION)
TABLE 190 US: NUTRACEUTICAL INGREDIENTS MARKET, BY ANIMAL NUTRITION, 2026-2031 (USD MILLION)
TABLE 191 CANADA: NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE, 2022-2025 (USD MILLION)
TABLE 192 CANADA: NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE, 2026-2031 (USD MILLION)
TABLE 193 CANADA: NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE, 2022-2025 (TONS)
TABLE 194 CANADA: NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE, 2026-2031 (TONS)
TABLE 195 CANADA: NUTRACEUTICAL INGREDIENTS MARKET, BY VITAMIN, 2022-2025 (USD MILLION)
TABLE 196 CANADA: NUTRACEUTICAL INGREDIENTS MARKET, BY VITAMIN, 2026-2031 (USD MILLION)
TABLE 197 CANADA: NUTRACEUTICAL INGREDIENTS MARKET, BY MINERAL, 2022-2025 (USD MILLION)
TABLE 198 CANADA: NUTRACEUTICAL INGREDIENTS MARKET, BY MINERAL, 2026-2031 (USD MILLION)
TABLE 199 CANADA: NUTRACEUTICAL INGREDIENTS MARKET, BY AMINO ACID, 2022-2025 (USD MILLION)
TABLE 200 CANADA: NUTRACEUTICAL INGREDIENTS MARKET, BY AMINO ACID, 2026-2031 (USD MILLION)
TABLE 201 CANADA: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2022-2025 (USD MILLION)
TABLE 202 CANADA: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2026-2031 (USD MILLION)
TABLE 203 CANADA: NUTRACEUTICAL INGREDIENTS MARKET, BY HUMAN NUTRITION, 2022-2025 (USD MILLION)
TABLE 204 CANADA: NUTRACEUTICAL INGREDIENTS MARKET, BY HUMAN NUTRITION, 2026-2031 (USD MILLION)
TABLE 205 CANADA: NUTRACEUTICAL INGREDIENTS MARKET, BY ANIMAL NUTRITION, 2022-2025 (USD MILLION)
TABLE 206 CANADA: NUTRACEUTICAL INGREDIENTS MARKET, BY ANIMAL NUTRITION, 2026-2031 (USD MILLION)
TABLE 207 MEXICO: NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE, 2022-2025 (USD MILLION)
TABLE 208 MEXICO: NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE, 2026-2031 (USD MILLION)
TABLE 209 MEXICO: NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE, 2022-2025 (TONS)
TABLE 210 MEXICO: NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE, 2026-2031 (TONS)
TABLE 211 MEXICO: NUTRACEUTICAL INGREDIENTS MARKET, BY VITAMIN, 2022-2025 (USD MILLION)
TABLE 212 MEXICO: NUTRACEUTICAL INGREDIENTS MARKET, BY VITAMIN, 2026-2031 (USD MILLION)
TABLE 213 MEXICO: NUTRACEUTICAL INGREDIENTS MARKET, BY MINERAL, 2022-2025 (USD MILLION)
TABLE 214 MEXICO: NUTRACEUTICAL INGREDIENTS MARKET, BY MINERAL, 2026-2031 (USD MILLION)
TABLE 215 MEXICO: NUTRACEUTICAL INGREDIENTS MARKET, BY AMINO ACID, 2022-2025 (USD MILLION)
TABLE 216 MEXICO: NUTRACEUTICAL INGREDIENTS MARKET, BY AMINO ACID, 2026-2031 (USD MILLION)
TABLE 217 MEXICO: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2022-2025 (USD MILLION)
TABLE 218 MEXICO: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2026-2031 (USD MILLION)
TABLE 219 MEXICO: NUTRACEUTICAL INGREDIENTS MARKET, BY HUMAN NUTRITION, 2022-2025 (USD MILLION)
TABLE 220 MEXICO: NUTRACEUTICAL INGREDIENTS MARKET, BY HUMAN NUTRITION, 2026-2031 (USD MILLION)
TABLE 221 MEXICO: NUTRACEUTICAL INGREDIENTS MARKET, BY ANIMAL NUTRITION, 2022-2025 (USD MILLION)
TABLE 222 MEXICO: NUTRACEUTICAL INGREDIENTS MARKET, BY ANIMAL NUTRITION, 2026-2031 (USD MILLION)
TABLE 223 EUROPE: NUTRACEUTICAL INGREDIENTS MARKET, BY COUNTRY, 2022-2025 (USD MILLION)
TABLE 224 EUROPE: NUTRACEUTICAL INGREDIENTS MARKET, BY COUNTRY, 2026-2031 (USD MILLION)
TABLE 225 EUROPE: NUTRACEUTICAL INGREDIENTS MARKET, BY COUNTRY, 2022-2025 (TONS)
TABLE 226 EUROPE: NUTRACEUTICAL INGREDIENTS MARKET, BY COUNTRY, 2026-2031 (TONS)
TABLE 227 EUROPE: NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE, 2022-2025 (USD MILLION)
TABLE 228 EUROPE: NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE, 2026-2031 (USD MILLION)
TABLE 229 EUROPE: NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE, 2022-2025 (TONS)
TABLE 230 EUROPE: NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE, 2026-2031 (TONS)
TABLE 231 EUROPE: NUTRACEUTICAL INGREDIENTS MARKET, BY VITAMIN, 2022-2025 (USD MILLION)
TABLE 232 EUROPE: NUTRACEUTICAL INGREDIENTS MARKET, BY VITAMIN, 2026-2031 (USD MILLION)
TABLE 233 EUROPE: NUTRACEUTICAL INGREDIENTS MARKET, BY MINERAL, 2022-2025 (USD MILLION)
TABLE 234 EUROPE: NUTRACEUTICAL INGREDIENTS MARKET, BY MINERAL, 2026-2031 (USD MILLION)
TABLE 235 EUROPE: NUTRACEUTICAL INGREDIENTS MARKET, BY AMINO ACID, 2022-2025 (USD MILLION)
TABLE 236 EUROPE: NUTRACEUTICAL INGREDIENTS MARKET, BY AMINO ACID, 2026-2031 (USD MILLION)
TABLE 237 EUROPE: NUTRACEUTICAL INGREDIENTS MARKET, BY SOURCE, 2022-2025 (USD MILLION)
TABLE 238 EUROPE: NUTRACEUTICAL INGREDIENTS MARKET, BY SOURCE, 2026-2031 (USD MILLION)
TABLE 239 EUROPE: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2022-2025 (USD MILLION)
TABLE 240 EUROPE: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2026-2031 (USD MILLION)
TABLE 241 EUROPE: NUTRACEUTICAL INGREDIENTS MARKET, BY HUMAN NUTRITION, 2022-2025 (USD MILLION)
TABLE 242 EUROPE: NUTRACEUTICAL INGREDIENTS MARKET, BY HUMAN NUTRITION, 2026-2031 (USD MILLION)
TABLE 243 EUROPE: NUTRACEUTICAL INGREDIENTS MARKET, BY ANIMAL NUTRITION, 2022-2025 (USD MILLION)
TABLE 244 EUROPE: NUTRACEUTICAL INGREDIENTS MARKET, BY ANIMAL NUTRITION, 2026-2031 (USD MILLION)
TABLE 245 GERMANY: NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE, 2022-2025 (USD MILLION)
TABLE 246 GERMANY: NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE, 2026-2031 (USD MILLION)
TABLE 247 GERMANY: NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE, 2022-2025 (TONS)
TABLE 248 GERMANY: NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE, 2026-2031 (TONS)
TABLE 249 GERMANY: NUTRACEUTICAL INGREDIENTS MARKET, BY VITAMIN, 2022-2025 (USD MILLION)
TABLE 250 GERMANY: NUTRACEUTICAL INGREDIENTS MARKET, BY VITAMIN, 2026-2031 (USD MILLION)
TABLE 251 GERMANY: NUTRACEUTICAL INGREDIENTS MARKET, BY MINERAL, 2022-2025 (USD MILLION)
TABLE 252 GERMANY: NUTRACEUTICAL INGREDIENTS MARKET, BY MINERAL, 2026-2031 (USD MILLION)
TABLE 253 GERMANY: NUTRACEUTICAL INGREDIENTS MARKET, BY AMINO ACID, 2022-2025 (USD MILLION)
TABLE 254 GERMANY: NUTRACEUTICAL INGREDIENTS MARKET, BY AMINO ACID, 2026-2031 (USD MILLION)
TABLE 255 GERMANY: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2022-2025 (USD MILLION)
TABLE 256 GERMANY: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2026-2031 (USD MILLION)
TABLE 257 GERMANY: NUTRACEUTICAL INGREDIENTS MARKET, BY HUMAN NUTRITION, 2022-2025 (USD MILLION)
TABLE 258 GERMANY: NUTRACEUTICAL INGREDIENTS MARKET, BY HUMAN NUTRITION, 2026-2031 (USD MILLION)
TABLE 259 GERMANY: NUTRACEUTICAL INGREDIENTS MARKET, BY ANIMAL NUTRITION, 2022-2025 (USD MILLION)
TABLE 260 GERMANY: NUTRACEUTICAL INGREDIENTS MARKET, BY ANIMAL NUTRITION, 2026-2031 (USD MILLION)
TABLE 261 UK: NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE, 2022-2025 (USD MILLION)
TABLE 262 UK: NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE, 2026-2031 (USD MILLION)
TABLE 263 UK: NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE, 2022-2025 (TONS)
TABLE 264 UK: NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE, 2026-2031 (TONS)
TABLE 265 UK: NUTRACEUTICAL INGREDIENTS MARKET, BY VITAMIN, 2022-2025 (USD MILLION)
TABLE 266 UK: NUTRACEUTICAL INGREDIENTS MARKET, BY VITAMIN, 2026-2031 (USD MILLION)
TABLE 267 UK: NUTRACEUTICAL INGREDIENTS MARKET, BY MINERAL, 2022-2025 (USD MILLION)
TABLE 268 UK: NUTRACEUTICAL INGREDIENTS MARKET, BY MINERAL, 2026-2031 (USD MILLION)
TABLE 269 UK: NUTRACEUTICAL INGREDIENTS MARKET, BY AMINO ACID, 2022-2025 (USD MILLION)
TABLE 270 UK: NUTRACEUTICAL INGREDIENTS MARKET, BY AMINO ACID, 2026-2031 (USD MILLION)
TABLE 271 UK: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2022-2025 (USD MILLION)
TABLE 272 UK: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2026-2031 (USD MILLION)
TABLE 273 UK: NUTRACEUTICAL INGREDIENTS MARKET, BY HUMAN NUTRITION, 2022-2025 (USD MILLION)
TABLE 274 UK: NUTRACEUTICAL INGREDIENTS MARKET, BY HUMAN NUTRITION, 2026-2031 (USD MILLION)
TABLE 275 UK: NUTRACEUTICAL INGREDIENTS MARKET, BY ANIMAL NUTRITION, 2022-2025 (USD MILLION)
TABLE 276 UK: NUTRACEUTICAL INGREDIENTS MARKET, BY ANIMAL NUTRITION, 2026-2031 (USD MILLION)
TABLE 277 FRANCE: NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE, 2022-2025 (USD MILLION)
TABLE 278 FRANCE: NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE, 2026-2031 (USD MILLION)
TABLE 279 FRANCE: NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE, 2022-2025 (TONS)
TABLE 280 FRANCE: NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE, 2026-2031 (TONS)
TABLE 281 FRANCE: NUTRACEUTICAL INGREDIENTS MARKET, BY VITAMIN, 2022-2025 (USD MILLION)
TABLE 282 FRANCE: NUTRACEUTICAL INGREDIENTS MARKET, BY VITAMIN, 2026-2031 (USD MILLION)
TABLE 283 FRANCE: NUTRACEUTICAL INGREDIENTS MARKET, BY MINERAL, 2022-2025 (USD MILLION)
TABLE 284 FRANCE: NUTRACEUTICAL INGREDIENTS MARKET, BY MINERAL, 2026-2031 (USD MILLION)
TABLE 285 FRANCE: NUTRACEUTICAL INGREDIENTS MARKET, BY AMINO ACID, 2022-2025 (USD MILLION)
TABLE 286 FRANCE: NUTRACEUTICAL INGREDIENTS MARKET, BY AMINO ACID, 2026-2031 (USD MILLION)
TABLE 287 FRANCE: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2022-2025 (USD MILLION)
TABLE 288 FRANCE: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2026-2031 (USD MILLION)
TABLE 289 FRANCE: NUTRACEUTICAL INGREDIENTS MARKET, BY HUMAN NUTRITION, 2022-2025 (USD MILLION)
TABLE 290 FRANCE: NUTRACEUTICAL INGREDIENTS MARKET, BY HUMAN NUTRITION, 2026-2031 (USD MILLION)
TABLE 291 FRANCE: NUTRACEUTICAL INGREDIENTS MARKET, BY ANIMAL NUTRITION, 2022-2025 (USD MILLION)
TABLE 292 FRANCE: NUTRACEUTICAL INGREDIENTS MARKET, BY ANIMAL NUTRITION, 2026-2031 (USD MILLION)
TABLE 293 ITALY: NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE, 2022-2025 (USD MILLION)
TABLE 294 ITALY: NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE, 2026-2031 (USD MILLION)
TABLE 295 ITALY: NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE, 2022-2025 (TONS)
TABLE 296 ITALY: NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE, 2026-2031 (TONS)
TABLE 297 ITALY: NUTRACEUTICAL INGREDIENTS MARKET, BY VITAMIN, 2022-2025 (USD MILLION)
TABLE 298 ITALY: NUTRACEUTICAL INGREDIENTS MARKET, BY VITAMIN, 2026-2031 (USD MILLION)
TABLE 299 ITALY: NUTRACEUTICAL INGREDIENTS MARKET, BY MINERAL, 2022-2025 (USD MILLION)
TABLE 300 ITALY: NUTRACEUTICAL INGREDIENTS MARKET, BY MINERAL, 2026-2031 (USD MILLION)
TABLE 301 ITALY: NUTRACEUTICAL INGREDIENTS MARKET, BY AMINO ACID, 2022-2025 (USD MILLION)
TABLE 302 ITALY: NUTRACEUTICAL INGREDIENTS MARKET, BY AMINO ACID, 2026-2031 (USD MILLION)
TABLE 303 ITALY: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2022-2025 (USD MILLION)
TABLE 304 ITALY: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2026-2031 (USD MILLION)
TABLE 305 ITALY: NUTRACEUTICAL INGREDIENTS MARKET, BY HUMAN NUTRITION, 2022-2025 (USD MILLION)
TABLE 306 ITALY: NUTRACEUTICAL INGREDIENTS MARKET, BY HUMAN NUTRITION, 2026-2031 (USD MILLION)
TABLE 307 ITALY: NUTRACEUTICAL INGREDIENTS MARKET, BY ANIMAL NUTRITION, 2022-2025 (USD MILLION)
TABLE 308 ITALY: NUTRACEUTICAL INGREDIENTS MARKET, BY ANIMAL NUTRITION, 2026-2031 (USD MILLION)
TABLE 309 SPAIN: NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE, 2022-2025 (USD MILLION)
TABLE 310 SPAIN: NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE, 2026-2031 (USD MILLION)
TABLE 311 SPAIN: NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE, 2022-2025 (TONS)
TABLE 312 SPAIN: NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE, 2026-2031 (TONS)
TABLE 313 SPAIN: NUTRACEUTICAL INGREDIENTS MARKET, BY VITAMIN, 2022-2025 (USD MILLION)
TABLE 314 SPAIN: NUTRACEUTICAL INGREDIENTS MARKET, BY VITAMIN, 2026-2031 (USD MILLION)
TABLE 315 SPAIN: NUTRACEUTICAL INGREDIENTS MARKET, BY MINERAL, 2022-2025 (USD MILLION)
TABLE 316 SPAIN: NUTRACEUTICAL INGREDIENTS MARKET, BY MINERAL, 2026-2031 (USD MILLION)
TABLE 317 SPAIN: NUTRACEUTICAL INGREDIENTS MARKET, BY AMINO ACID, 2022-2025 (USD MILLION)
TABLE 318 SPAIN: NUTRACEUTICAL INGREDIENTS MARKET, BY AMINO ACID, 2026-2031 (USD MILLION)
TABLE 319 SPAIN: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2022-2025 (USD MILLION)
TABLE 320 SPAIN: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2026-2031 (USD MILLION)
TABLE 321 SPAIN: NUTRACEUTICAL INGREDIENTS MARKET, BY HUMAN NUTRITION, 2022-2025 (USD MILLION)
TABLE 322 SPAIN: NUTRACEUTICAL INGREDIENTS MARKET, BY HUMAN NUTRITION, 2026-2031 (USD MILLION)
TABLE 323 SPAIN: NUTRACEUTICAL INGREDIENTS MARKET, BY ANIMAL NUTRITION, 2022-2025 (USD MILLION)
TABLE 324 SPAIN: NUTRACEUTICAL INGREDIENTS MARKET, BY ANIMAL NUTRITION, 2026-2031 (USD MILLION)
TABLE 325 REST OF EUROPE: NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE, 2022-2025 (USD MILLION)
TABLE 326 REST OF EUROPE: NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE, 2026-2031 (USD MILLION)
TABLE 327 REST OF EUROPE: NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE, 2022-2025 (TONS)
TABLE 328 REST OF EUROPE: NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE, 2026-2031 (TONS)
TABLE 329 REST OF EUROPE: NUTRACEUTICAL INGREDIENTS MARKET, BY VITAMIN, 2022-2025 (USD MILLION)
TABLE 330 REST OF EUROPE: NUTRACEUTICAL INGREDIENTS MARKET, BY VITAMIN, 2026-2031 (USD MILLION)
TABLE 331 REST OF EUROPE: NUTRACEUTICAL INGREDIENTS MARKET, BY MINERAL, 2022-2025 (USD MILLION)
TABLE 332 REST OF EUROPE: NUTRACEUTICAL INGREDIENTS MARKET, BY MINERAL, 2026-2031 (USD MILLION)
TABLE 333 REST OF EUROPE: NUTRACEUTICAL INGREDIENTS MARKET, BY AMINO ACID, 2022-2025 (USD MILLION)
TABLE 334 REST OF EUROPE: NUTRACEUTICAL INGREDIENTS MARKET, BY AMINO ACID, 2026-2031 (USD MILLION)
TABLE 335 REST OF EUROPE: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2022-2025 (USD MILLION)
TABLE 336 REST OF EUROPE: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2026-2031 (USD MILLION)
TABLE 337 REST OF EUROPE: NUTRACEUTICAL INGREDIENTS MARKET, BY HUMAN NUTRITION, 2022-2025 (USD MILLION)
TABLE 338 REST OF EUROPE: NUTRACEUTICAL INGREDIENTS MARKET, BY HUMAN NUTRITION, 2026-2031 (USD MILLION)
TABLE 339 REST OF EUROPE: NUTRACEUTICAL INGREDIENTS MARKET, BY ANIMAL NUTRITION, 2022-2025 (USD MILLION)
TABLE 340 REST OF EUROPE: NUTRACEUTICAL INGREDIENTS MARKET, BY ANIMAL NUTRITION, 2026-2031 (USD MILLION)
TABLE 341 ASIA PACIFIC: NUTRACEUTICAL INGREDIENTS MARKET, BY COUNTRY, 2022-2025 (USD MILLION)
TABLE 342 ASIA PACIFIC: NUTRACEUTICAL INGREDIENTS MARKET, BY COUNTRY, 2026-2031 (USD MILLION)
TABLE 343 ASIA PACIFIC: NUTRACEUTICAL INGREDIENTS MARKET, BY COUNTRY, 2022-2025 (TONS)
TABLE 344 ASIA PACIFIC: NUTRACEUTICAL INGREDIENTS MARKET, BY COUNTRY, 2026-2031 (TONS)
TABLE 345 ASIA PACIFIC: NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE, 2022-2025 (USD MILLION)
TABLE 346 ASIA PACIFIC: NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE, 2026-2031 (USD MILLION)
TABLE 347 ASIA PACIFIC: NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE, 2022-2025 (TONS)
TABLE 348 ASIA PACIFIC: NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE, 2026-2031 (TONS)
TABLE 349 ASIA PACIFIC: NUTRACEUTICAL INGREDIENTS MARKET, BY VITAMIN, 2022-2025 (USD MILLION)
TABLE 350 ASIA PACIFIC: NUTRACEUTICAL INGREDIENTS MARKET, BY VITAMIN, 2026-2031 (USD MILLION)
TABLE 351 ASIA PACIFIC: NUTRACEUTICAL INGREDIENTS MARKET, BY MINERAL, 2022-2025 (USD MILLION)
TABLE 352 ASIA PACIFIC: NUTRACEUTICAL INGREDIENTS MARKET, BY MINERAL, 2026-2031 (USD MILLION)
TABLE 353 ASIA PACIFIC: NUTRACEUTICAL INGREDIENTS MARKET, BY AMINO ACID, 2022-2025 (USD MILLION)
TABLE 354 ASIA PACIFIC: NUTRACEUTICAL INGREDIENTS MARKET, BY AMINO ACID, 2026-2031 (USD MILLION)
TABLE 355 ASIA PACIFIC: NUTRACEUTICAL INGREDIENTS MARKET, BY SOURCE, 2022-2025 (USD MILLION)
TABLE 356 ASIA PACIFIC: NUTRACEUTICAL INGREDIENTS MARKET, BY SOURCE, 2026-2031 (USD MILLION)
TABLE 357 ASIA PACIFIC: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2022-2025 (USD MILLION)
TABLE 358 ASIA PACIFIC: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2026-2031 (USD MILLION)
TABLE 359 ASIA PACIFIC: NUTRACEUTICAL INGREDIENTS MARKET, BY HUMAN NUTRITION, 2022-2025 (USD MILLION)
TABLE 360 ASIA PACIFIC: NUTRACEUTICAL INGREDIENTS MARKET, BY HUMAN NUTRITION, 2026-2031 (USD MILLION)
TABLE 361 ASIA PACIFIC: NUTRACEUTICAL INGREDIENTS MARKET, BY ANIMAL NUTRITION, 2022-2025 (USD MILLION)
TABLE 362 ASIA PACIFIC: NUTRACEUTICAL INGREDIENTS MARKET, BY ANIMAL NUTRITION, 2026-2031 (USD MILLION)
TABLE 363 CHINA: NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE, 2022-2025 (USD MILLION)
TABLE 364 CHINA: NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE, 2026-2031 (USD MILLION)
TABLE 365 CHINA: NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE, 2022-2025 (TONS)
TABLE 366 CHINA: NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE, 2026-2031 (TONS)
TABLE 367 CHINA: NUTRACEUTICAL INGREDIENTS MARKET, BY VITAMIN, 2022-2025 (USD MILLION)
TABLE 368 CHINA: NUTRACEUTICAL INGREDIENTS MARKET, BY VITAMIN, 2026-2031 (USD MILLION)
TABLE 369 CHINA: NUTRACEUTICAL INGREDIENTS MARKET, BY MINERAL, 2022-2025 (USD MILLION)
TABLE 370 CHINA: NUTRACEUTICAL INGREDIENTS MARKET, BY MINERAL, 2026-2031 (USD MILLION)
TABLE 371 CHINA: NUTRACEUTICAL INGREDIENTS MARKET, BY AMINO ACID, 2022-2025 (USD MILLION)
TABLE 372 CHINA: NUTRACEUTICAL INGREDIENTS MARKET, BY AMINO ACID, 2026-2031 (USD MILLION)
TABLE 373 CHINA: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2022-2025 (USD MILLION)
TABLE 374 CHINA: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2026-2031 (USD MILLION)
TABLE 375 CHINA: NUTRACEUTICAL INGREDIENTS MARKET, BY HUMAN NUTRITION, 2022-2025 (USD MILLION)
TABLE 376 CHINA: NUTRACEUTICAL INGREDIENTS MARKET, BY HUMAN NUTRITION, 2026-2031 (USD MILLION)
TABLE 377 CHINA: NUTRACEUTICAL INGREDIENTS MARKET, BY ANIMAL NUTRITION, 2022-2025 (USD MILLION)
TABLE 378 CHINA: NUTRACEUTICAL INGREDIENTS MARKET, BY ANIMAL NUTRITION, 2026-2031 (USD MILLION)
TABLE 379 INDIA: NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE, 2022-2025 (USD MILLION)
TABLE 380 INDIA: NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE, 2026-2031 (USD MILLION)
TABLE 381 INDIA: NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE, 2022-2025 (TONS)
TABLE 382 INDIA: NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE, 2026-2031 (TONS)
TABLE 383 INDIA: NUTRACEUTICAL INGREDIENTS MARKET, BY VITAMIN, 2022-2025 (USD MILLION)
TABLE 384 INDIA: NUTRACEUTICAL INGREDIENTS MARKET, BY VITAMIN, 2026-2031 (USD MILLION)
TABLE 385 INDIA: NUTRACEUTICAL INGREDIENTS MARKET, BY MINERAL, 2022-2025 (USD MILLION)
TABLE 386 INDIA: NUTRACEUTICAL INGREDIENTS MARKET, BY MINERAL, 2026-2031 (USD MILLION)
TABLE 387 INDIA: NUTRACEUTICAL INGREDIENTS MARKET, BY AMINO ACID, 2022-2025 (USD MILLION)
TABLE 388 INDIA: NUTRACEUTICAL INGREDIENTS MARKET, BY AMINO ACID, 2026-2031 (USD MILLION)
TABLE 389 INDIA: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2022-2025 (USD MILLION)
TABLE 390 INDIA: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2026-2031 (USD MILLION)
TABLE 391 INDIA: NUTRACEUTICAL INGREDIENTS MARKET, BY HUMAN NUTRITION, 2022-2025 (USD MILLION)
TABLE 392 INDIA: NUTRACEUTICAL INGREDIENTS MARKET, BY HUMAN NUTRITION, 2026-2031 (USD MILLION)
TABLE 393 INDIA: NUTRACEUTICAL INGREDIENTS MARKET, BY ANIMAL NUTRITION, 2022-2025 (USD MILLION)
TABLE 394 INDIA: NUTRACEUTICAL INGREDIENTS MARKET, BY ANIMAL NUTRITION, 2026-2031 (USD MILLION)
TABLE 395 JAPAN: NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE, 2022-2025 (USD MILLION)
TABLE 396 JAPAN: NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE, 2026-2031 (USD MILLION)
TABLE 397 JAPAN: NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE, 2022-2025 (TONS)
TABLE 398 JAPAN: NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE, 2026-2031 (TONS)
TABLE 399 JAPAN: NUTRACEUTICAL INGREDIENTS MARKET, BY VITAMIN, 2022-2025 (USD MILLION)
TABLE 400 JAPAN: NUTRACEUTICAL INGREDIENTS MARKET, BY VITAMIN, 2026-2031 (USD MILLION)
TABLE 401 JAPAN: NUTRACEUTICAL INGREDIENTS MARKET, BY MINERAL, 2022-2025 (USD MILLION)
TABLE 402 JAPAN: NUTRACEUTICAL INGREDIENTS MARKET, BY MINERAL, 2026-2031 (USD MILLION)
TABLE 403 JAPAN: NUTRACEUTICAL INGREDIENTS MARKET, BY AMINO ACID, 2022-2025 (USD MILLION)
TABLE 404 JAPAN: NUTRACEUTICAL INGREDIENTS MARKET, BY AMINO ACID, 2026-2031 (USD MILLION)
TABLE 405 JAPAN: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2022-2025 (USD MILLION)
TABLE 406 JAPAN: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2026-2031 (USD MILLION)
TABLE 407 JAPAN: NUTRACEUTICAL INGREDIENTS MARKET, BY HUMAN NUTRITION, 2022-2025 (USD MILLION)
TABLE 408 JAPAN: NUTRACEUTICAL INGREDIENTS MARKET, BY HUMAN NUTRITION, 2026-2031 (USD MILLION)
TABLE 409 JAPAN: NUTRACEUTICAL INGREDIENTS MARKET, BY ANIMAL NUTRITION, 2022-2025 (USD MILLION)
TABLE 410 JAPAN: NUTRACEUTICAL INGREDIENTS MARKET, BY ANIMAL NUTRITION, 2026-2031 (USD MILLION)
TABLE 411 AUSTRALIA AND NEW ZEALAND: NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE, 2022-2025 (USD MILLION)
TABLE 412 AUSTRALIA AND NEW ZEALAND: NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE, 2026-2031 (USD MILLION)
TABLE 413 AUSTRALIA AND NEW ZEALAND: NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE, 2022-2025 (TONS)
TABLE 414 AUSTRALIA AND NEW ZEALAND: NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE, 2026-2031 (TONS)
TABLE 415 AUSTRALIA AND NEW ZEALAND: NUTRACEUTICAL INGREDIENTS MARKET, BY VITAMIN, 2022-2025 (USD MILLION)
TABLE 416 AUSTRALIA AND NEW ZEALAND: NUTRACEUTICAL INGREDIENTS MARKET, BY VITAMIN, 2026-2031 (USD MILLION)
TABLE 417 AUSTRALIA AND NEW ZEALAND: NUTRACEUTICAL INGREDIENTS MARKET, BY MINERAL, 2022-2025 (USD MILLION)
TABLE 418 AUSTRALIA AND NEW ZEALAND: NUTRACEUTICAL INGREDIENTS MARKET, BY MINERAL, 2026-2031 (USD MILLION)
TABLE 419 AUSTRALIA AND NEW ZEALAND: NUTRACEUTICAL INGREDIENTS MARKET, BY AMINO ACID, 2022-2025 (USD MILLION)
TABLE 420 AUSTRALIA AND NEW ZEALAND: NUTRACEUTICAL INGREDIENTS MARKET, BY AMINO ACID, 2026-2031 (USD MILLION)
TABLE 421 AUSTRALIA AND NEW ZEALAND: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2022-2025 (USD MILLION)
TABLE 422 AUSTRALIA AND NEW ZEALAND: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2026-2031 (USD MILLION)
TABLE 423 AUSTRALIA AND NEW ZEALAND: NUTRACEUTICAL INGREDIENTS MARKET, BY HUMAN NUTRITION, 2022-2025 (USD MILLION)
TABLE 424 AUSTRALIA AND NEW ZEALAND: NUTRACEUTICAL INGREDIENTS MARKET, BY HUMAN NUTRITION, 2026-2031 (USD MILLION)
TABLE 425 AUSTRALIA AND NEW ZEALAND: NUTRACEUTICAL INGREDIENTS MARKET, BY ANIMAL NUTRITION, 2022-2025 (USD MILLION)
TABLE 426 AUSTRALIA AND NEW ZEALAND: NUTRACEUTICAL INGREDIENTS MARKET, BY ANIMAL NUTRITION, 2026-2031 (USD MILLION)
TABLE 427 REST OF ASIA PACIFIC: NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE, 2022-2025 (USD MILLION)
TABLE 428 REST OF ASIA PACIFIC: NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE, 2026-2031 (USD MILLION)
TABLE 429 REST OF ASIA PACIFIC: NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE, 2022-2025 (TONS)
TABLE 430 REST OF ASIA PACIFIC: NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE, 2026-2031 (TONS)
TABLE 431 REST OF ASIA PACIFIC: NUTRACEUTICAL INGREDIENTS MARKET, BY VITAMIN, 2022-2025 (USD MILLION)
TABLE 432 REST OF ASIA PACIFIC: NUTRACEUTICAL INGREDIENTS MARKET, BY VITAMIN, 2026-2031 (USD MILLION)
TABLE 433 REST OF ASIA PACIFIC: NUTRACEUTICAL INGREDIENTS MARKET, BY MINERAL, 2022-2025 (USD MILLION)
TABLE 434 REST OF ASIA PACIFIC: NUTRACEUTICAL INGREDIENTS MARKET, BY MINERAL, 2026-2031 (USD MILLION)
TABLE 435 REST OF ASIA PACIFIC: NUTRACEUTICAL INGREDIENTS MARKET, BY AMINO ACID, 2022-2025 (USD MILLION)
TABLE 436 REST OF ASIA PACIFIC: NUTRACEUTICAL INGREDIENTS MARKET, BY AMINO ACID, 2026-2031 (USD MILLION)
TABLE 437 REST OF ASIA PACIFIC: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2022-2025 (USD MILLION)
TABLE 438 REST OF ASIA PACIFIC: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2026-2031 (USD MILLION)
TABLE 439 REST OF ASIA PACIFIC: NUTRACEUTICAL INGREDIENTS MARKET, BY HUMAN NUTRITION, 2022-2025 (USD MILLION)
TABLE 440 REST OF ASIA PACIFIC: NUTRACEUTICAL INGREDIENTS MARKET, BY HUMAN NUTRITION, 2026-2031 (USD MILLION)
TABLE 441 REST OF ASIA PACIFIC: NUTRACEUTICAL INGREDIENTS MARKET, BY ANIMAL NUTRITION, 2022-2025 (USD MILLION)
TABLE 442 REST OF ASIA PACIFIC: NUTRACEUTICAL INGREDIENTS MARKET, BY ANIMAL NUTRITION, 2026-2031 (USD MILLION)
TABLE 443 SOUTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY COUNTRY, 2022-2025 (USD MILLION)
TABLE 444 SOUTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY COUNTRY, 2026-2031 (USD MILLION)
TABLE 445 SOUTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY COUNTRY, 2022-2025 (TONS)
TABLE 446 SOUTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY COUNTRY, 2026-2031 (TONS)
TABLE 447 SOUTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE, 2022-2025 (USD MILLION)
TABLE 448 SOUTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE, 2026-2031 (USD MILLION)
TABLE 449 SOUTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE, 2022-2025 (TONS)
TABLE 450 SOUTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE, 2026-2031 (TONS)
TABLE 451 SOUTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY VITAMIN, 2022-2025 (USD MILLION)
TABLE 452 SOUTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY VITAMIN, 2026-2031 (USD MILLION)
TABLE 453 SOUTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY MINERAL, 2022-2025 (USD MILLION)
TABLE 454 SOUTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY MINERAL, 2026-2031 (USD MILLION)
TABLE 455 SOUTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY AMINO ACID, 2022-2025 (USD MILLION)
TABLE 456 SOUTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY AMINO ACID, 2026-2031 (USD MILLION)
TABLE 457 SOUTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY SOURCE, 2022-2025 (USD MILLION)
TABLE 458 SOUTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY SOURCE, 2026-2031 (USD MILLION)
TABLE 459 SOUTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2022-2025 (USD MILLION)
TABLE 460 SOUTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2026-2031 (USD MILLION)
TABLE 461 SOUTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY HUMAN NUTRITION, 2022-2025 (USD MILLION)
TABLE 462 SOUTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY HUMAN NUTRITION, 2026-2031 (USD MILLION)
TABLE 463 SOUTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY ANIMAL NUTRITION, 2022-2025 (USD MILLION)
TABLE 464 SOUTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY ANIMAL NUTRITION, 2026-2031 (USD MILLION)
TABLE 465 BRAZIL: NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE, 2022-2025 (USD MILLION)
TABLE 466 BRAZIL: NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE, 2026-2031 (USD MILLION)
TABLE 467 BRAZIL: NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE, 2022-2025 (TONS)
TABLE 468 BRAZIL: NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE, 2026-2031 (TONS)
TABLE 469 BRAZIL: NUTRACEUTICAL INGREDIENTS MARKET, BY VITAMIN, 2022-2025 (USD MILLION)
TABLE 470 BRAZIL: NUTRACEUTICAL INGREDIENTS MARKET, BY VITAMIN, 2026-2031 (USD MILLION)
TABLE 471 BRAZIL: NUTRACEUTICAL INGREDIENTS MARKET, BY MINERAL, 2022-2025 (USD MILLION)
TABLE 472 BRAZIL: NUTRACEUTICAL INGREDIENTS MARKET, BY MINERAL, 2026-2031 (USD MILLION)
TABLE 473 BRAZIL: NUTRACEUTICAL INGREDIENTS MARKET, BY AMINO ACID, 2022-2025 (USD MILLION)
TABLE 474 BRAZIL: NUTRACEUTICAL INGREDIENTS MARKET, BY AMINO ACID, 2026-2031 (USD MILLION)
TABLE 475 BRAZIL: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2022-2025 (USD MILLION)
TABLE 476 BRAZIL: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2026-2031 (USD MILLION)
TABLE 477 BRAZIL: NUTRACEUTICAL INGREDIENTS MARKET, BY HUMAN NUTRITION, 2022-2025 (USD MILLION)
TABLE 478 BRAZIL: NUTRACEUTICAL INGREDIENTS MARKET, BY HUMAN NUTRITION, 2026-2031 (USD MILLION)
TABLE 479 BRAZIL: NUTRACEUTICAL INGREDIENTS MARKET, BY ANIMAL NUTRITION, 2022-2025 (USD MILLION)
TABLE 480 BRAZIL: NUTRACEUTICAL INGREDIENTS MARKET, BY ANIMAL NUTRITION, 2026-2031 (USD MILLION)
TABLE 481 ARGENTINA: NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE, 2022-2025 (USD MILLION)
TABLE 482 ARGENTINA: NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE, 2026-2031 (USD MILLION)
TABLE 483 ARGENTINA: NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE, 2022-2025 (TONS)
TABLE 484 ARGENTINA: NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE, 2026-2031 (TONS)
TABLE 485 ARGENTINA: NUTRACEUTICAL INGREDIENTS MARKET, BY VITAMIN, 2022-2025 (USD MILLION)
TABLE 486 ARGENTINA: NUTRACEUTICAL INGREDIENTS MARKET, BY VITAMIN, 2026-2031 (USD MILLION)
TABLE 487 ARGENTINA: NUTRACEUTICAL INGREDIENTS MARKET, BY MINERAL, 2022-2025 (USD MILLION)
TABLE 488 ARGENTINA: NUTRACEUTICAL INGREDIENTS MARKET, BY MINERAL, 2026-2031 (USD MILLION)
TABLE 489 ARGENTINA: NUTRACEUTICAL INGREDIENTS MARKET, BY AMINO ACID, 2022-2025 (USD MILLION)
TABLE 490 ARGENTINA: NUTRACEUTICAL INGREDIENTS MARKET, BY AMINO ACID, 2026-2031 (USD MILLION)
TABLE 491 ARGENTINA: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2022-2025 (USD MILLION)
TABLE 492 ARGENTINA: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2026-2031 (USD MILLION)
TABLE 493 ARGENTINA: NUTRACEUTICAL INGREDIENTS MARKET, BY HUMAN NUTRITION, 2022-2025 (USD MILLION)
TABLE 494 ARGENTINA: NUTRACEUTICAL INGREDIENTS MARKET, BY HUMAN NUTRITION, 2026-2031 (USD MILLION)
TABLE 495 ARGENTINA: NUTRACEUTICAL INGREDIENTS MARKET, BY ANIMAL NUTRITION, 2022-2025 (USD MILLION)
TABLE 496 ARGENTINA: NUTRACEUTICAL INGREDIENTS MARKET, BY ANIMAL NUTRITION, 2026-2031 (USD MILLION)
TABLE 497 REST OF SOUTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE, 2022-2025 (USD MILLION)
TABLE 498 REST OF SOUTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE, 2026-2031 (USD MILLION)
TABLE 499 REST OF SOUTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE, 2022-2025 (TONS)
TABLE 500 REST OF SOUTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE, 2026-2031 (TONS)
TABLE 501 REST OF SOUTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY VITAMIN, 2022-2025 (USD MILLION)
TABLE 502 REST OF SOUTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY VITAMIN, 2026-2031 (USD MILLION)
TABLE 503 REST OF SOUTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY MINERAL, 2022-2025 (USD MILLION)
TABLE 504 REST OF SOUTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY MINERAL, 2026-2031 (USD MILLION)
TABLE 505 REST OF SOUTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY AMINO ACID, 2022-2025 (USD MILLION)
TABLE 506 REST OF SOUTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY AMINO ACID, 2026-2031 (USD MILLION)
TABLE 507 REST OF SOUTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2022-2025 (USD MILLION)
TABLE 508 REST OF SOUTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2026-2031 (USD MILLION)
TABLE 509 REST OF SOUTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY HUMAN NUTRITION, 2022-2025 (USD MILLION)
TABLE 510 REST OF SOUTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY HUMAN NUTRITION, 2026-2031 (USD MILLION)
TABLE 511 REST OF SOUTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY ANIMAL NUTRITION, 2022-2025 (USD MILLION)
TABLE 512 REST OF SOUTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY ANIMAL NUTRITION, 2026-2031 (USD MILLION)
TABLE 513 ROW: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2022-2025 (USD MILLION)
TABLE 514 ROW: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2026-2031 (USD MILLION)
TABLE 515 ROW: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2022-2025 (TONS)
TABLE 516 ROW: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2026-2031 (TONS)
TABLE 517 ROW: NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE, 2022-2025 (USD MILLION)
TABLE 518 ROW: NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE, 2026-2031 (USD MILLION)
TABLE 519 ROW: NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE, 2022-2025 (TONS)
TABLE 520 ROW: NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE, 2026-2031 (TONS)
TABLE 521 ROW: NUTRACEUTICAL INGREDIENTS MARKET, BY VITAMIN, 2022-2025 (USD MILLION)
TABLE 522 ROW: NUTRACEUTICAL INGREDIENTS MARKET, BY VITAMIN, 2026-2031 (USD MILLION)
TABLE 523 ROW: NUTRACEUTICAL INGREDIENTS MARKET, BY MINERAL, 2022-2025 (USD MILLION)
TABLE 524 ROW: NUTRACEUTICAL INGREDIENTS MARKET, BY MINERAL, 2026-2031 (USD MILLION)
TABLE 525 ROW: NUTRACEUTICAL INGREDIENTS MARKET, BY AMINO ACID, 2022-2025 (USD MILLION)
TABLE 526 ROW: NUTRACEUTICAL INGREDIENTS MARKET, BY AMINO ACID, 2026-2031 (USD MILLION)
TABLE 527 ROW: NUTRACEUTICAL INGREDIENTS MARKET, BY SOURCE, 2022-2025 (USD MILLION)
TABLE 528 ROW: NUTRACEUTICAL INGREDIENTS MARKET, BY SOURCE, 2026-2031 (USD MILLION)
TABLE 529 ROW: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2022-2025 (USD MILLION)
TABLE 530 ROW: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2026-2031 (USD MILLION)
TABLE 531 ROW: NUTRACEUTICAL INGREDIENTS MARKET, BY HUMAN NUTRITION, 2022-2025 (USD MILLION)
TABLE 532 ROW: NUTRACEUTICAL INGREDIENTS MARKET, BY HUMAN NUTRITION, 2026-2031 (USD MILLION)
TABLE 533 ROW: NUTRACEUTICAL INGREDIENTS MARKET, BY ANIMAL NUTRITION, 2022-2025 (USD MILLION)
TABLE 534 ROW: NUTRACEUTICAL INGREDIENTS MARKET, BY ANIMAL NUTRITION, 2026-2031 (USD MILLION)
TABLE 535 MIDDLE EAST: NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE, 2022-2025 (USD MILLION)
TABLE 536 MIDDLE EAST: NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE, 2026-2031 (USD MILLION)
TABLE 537 MIDDLE EAST: NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE, 2022-2025 (TONS)
TABLE 538 MIDDLE EAST: NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE, 2026-2031 (TONS)
TABLE 539 MIDDLE EAST: NUTRACEUTICAL INGREDIENTS MARKET, BY VITAMIN, 2022-2025 (USD MILLION)
TABLE 540 MIDDLE EAST: NUTRACEUTICAL INGREDIENTS MARKET, BY VITAMIN, 2026-2031 (USD MILLION)
TABLE 541 MIDDLE EAST: NUTRACEUTICAL INGREDIENTS MARKET, BY MINERAL, 2022-2025 (USD MILLION)
TABLE 542 MIDDLE EAST: NUTRACEUTICAL INGREDIENTS MARKET, BY MINERAL, 2026-2031 (USD MILLION)
TABLE 543 MIDDLE EAST: NUTRACEUTICAL INGREDIENTS MARKET, BY AMINO ACID, 2022-2025 (USD MILLION)
TABLE 544 MIDDLE EAST: NUTRACEUTICAL INGREDIENTS MARKET, BY AMINO ACID, 2026-2031 (USD MILLION)
TABLE 545 MIDDLE EAST: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2022-2025 (USD MILLION)
TABLE 546 MIDDLE EAST: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2026-2031 (USD MILLION)
TABLE 547 MIDDLE EAST: NUTRACEUTICAL INGREDIENTS MARKET, BY HUMAN NUTRITION, 2022-2025 (USD MILLION)
TABLE 548 MIDDLE EAST: NUTRACEUTICAL INGREDIENTS MARKET, BY HUMAN NUTRITION, 2026-2031 (USD MILLION)
TABLE 549 MIDDLE EAST: NUTRACEUTICAL INGREDIENTS MARKET, BY ANIMAL NUTRITION, 2022-2025 (USD MILLION)
TABLE 550 MIDDLE EAST: NUTRACEUTICAL INGREDIENTS MARKET, BY ANIMAL NUTRITION, 2026-2031 (USD MILLION)
TABLE 551 AFRICA: NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE, 2022-2025 (USD MILLION)
TABLE 552 AFRICA: NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE, 2026-2031 (USD MILLION)
TABLE 553 AFRICA: NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE, 2022-2025 (TONS)
TABLE 554 AFRICA: NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE, 2026-2031 (TONS)
TABLE 555 AFRICA: NUTRACEUTICAL INGREDIENTS MARKET, BY VITAMIN, 2022-2025 (USD MILLION)
TABLE 556 AFRICA: NUTRACEUTICAL INGREDIENTS MARKET, BY VITAMIN, 2026-2031 (USD MILLION)
TABLE 557 AFRICA: NUTRACEUTICAL INGREDIENTS MARKET, BY MINERAL, 2022-2025 (USD MILLION)
TABLE 558 AFRICA: NUTRACEUTICAL INGREDIENTS MARKET, BY MINERAL, 2026-2031 (USD MILLION)
TABLE 559 AFRICA: NUTRACEUTICAL INGREDIENTS MARKET, BY AMINO ACID, 2022-2025 (USD MILLION)
TABLE 560 AFRICA: NUTRACEUTICAL INGREDIENTS MARKET, BY AMINO ACID, 2026-2031 (USD MILLION)
TABLE 561 AFRICA: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2022-2025 (USD MILLION)
TABLE 562 AFRICA: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2026-2031 (USD MILLION)
TABLE 563 AFRICA: NUTRACEUTICAL INGREDIENTS MARKET, BY HUMAN NUTRITION, 2022-2025 (USD MILLION)
TABLE 564 AFRICA: NUTRACEUTICAL INGREDIENTS MARKET, BY HUMAN NUTRITION, 2026-2031 (USD MILLION)
TABLE 565 AFRICA: NUTRACEUTICAL INGREDIENTS MARKET, BY ANIMAL NUTRITION, 2022-2025 (USD MILLION)
TABLE 566 AFRICA: NUTRACEUTICAL INGREDIENTS MARKET, BY ANIMAL NUTRITION, 2026-2031 (USD MILLION)
TABLE 567 COMPETITIVE STRATEGIES INITIATIVES IN NUTRACEUTICAL INGREDIENTS MARKET
TABLE 568 NUTRACEUTICAL INGREDIENTS MARKET: DEGREE OF COMPETITION
TABLE 569 NUTRACEUTICAL INGREDIENTS MARKET: REGION FOOTPRINT
TABLE 570 NUTRACEUTICAL INGREDIENTS MARKET: INGREDIENT TYPE FOOTPRINT
TABLE 571 NUTRACEUTICAL INGREDIENTS MARKET: SOURCE FOOTPRINT
TABLE 572 NUTRACEUTICAL INGREDIENTS MARKET: APPLICATION FOOTPRINT
TABLE 573 NUTRACEUTICAL INGREDIENTS MARKET: KEY STARTUPS/SMES
TABLE 574 NUTRACEUTICAL INGREDIENTS MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES, 2025
TABLE 575 NUTRACEUTICAL INGREDIENTS MARKET: PRODUCT LAUNCHES, 2021-AUGUST 2026
TABLE 576 NUTRACEUTICAL INGREDIENTS MARKET: DEALS, 2021-AUGUST 2026
TABLE 577 NUTRACEUTICAL INGREDIENTS MARKET: EXPANSIONS, 2021-AUGUST 2026
TABLE 578 CARGILL, INCORPORATED: COMPANY OVERVIEW
TABLE 579 CARGILL, INCORPORATED: PRODUCTS OFFERED
TABLE 580 CARGILL, INCORPORATED: PRODUCT LAUNCHES
TABLE 581 CARGILL, INCORPORATED: DEALS
TABLE 582 CARGILL, INCORPORATED: EXPANSIONS
TABLE 583 CARGILL, INCORPORATED: OTHER DEVELOPMENTS
TABLE 584 ADM: COMPANY OVERVIEW
TABLE 585 ADM: PRODUCTS OFFERED
TABLE 586 ADM: PRODUCT LAUNCHES
TABLE 587 ADM: DEALS
TABLE 588 ADM: EXPANSIONS
TABLE 589 ADM: OTHER DEVELOPMENTS
TABLE 590 INTERNATIONAL FLAVORS & FRAGRANCES INC.: COMPANY OVERVIEW
TABLE 591 INTERNATIONAL FLAVORS & FRAGRANCES INC.: PRODUCTS OFFERED
TABLE 592 INTERNATIONAL FLAVORS & FRAGRANCES INC.: PRODUCT LAUNCHES
TABLE 593 INTERNATIONAL FLAVORS & FRAGRANCES INC.: DEALS
TABLE 594 INTERNATIONAL FLAVORS & FRAGRANCES INC.: EXPANSIONS
TABLE 595 INTERNATIONAL FLAVORS & FRAGRANCES INC.: OTHER DEVELOPMENTS
TABLE 596 BASF: COMPANY OVERVIEW
TABLE 597 BASF: PRODUCTS OFFERED
TABLE 598 BASF: PRODUCT LAUNCHES
TABLE 599 BASF: DEALS
TABLE 600 BASF: EXPANSIONS
TABLE 601 BASF: OTHER DEVELOPMENTS
TABLE 602 GLANBIA PLC: COMPANY OVERVIEW
TABLE 603 GLANBIA PLC: PRODUCTS OFFERED
TABLE 604 GLANBIA PLC: PRODUCT LAUNCHES
TABLE 605 GLANBIA PLC: DEALS
TABLE 606 GLANBIA PLC: EXPANSIONS
TABLE 607 GLANBIA PLC: OTHER DEVELOPMENTS
TABLE 608 ARLA FOODS AMBA: COMPANY OVERVIEW
TABLE 609 ARLA FOODS AMBA: PRODUCTS OFFERED
TABLE 610 ARLA FOODS AMBA: PRODUCT LAUNCHES
TABLE 611 ARLA FOODS AMBA: DEALS
TABLE 612 ARLA FOODS AMBA: EXPANSIONS
TABLE 613 ARLA FOODS AMBA: OTHER DEVELOPMENTS
TABLE 614 DSM-FIRMENICH: COMPANY OVERVIEW
TABLE 615 DSM-FIRMENICH: PRODUCTS OFFERED
TABLE 616 DSM-FIRMENICH: PRODUCT LAUNCHES
TABLE 617 DSM-FIRMENICH: DEALS
TABLE 618 DSM-FIRMENICH: EXPANSIONS
TABLE 619 DSM-FIRMENICH: OTHER DEVELOPMENTS
TABLE 620 INGREDION: COMPANY OVERVIEW
TABLE 621 INGREDION: PRODUCTS OFFERED
TABLE 622 INGREDION: PRODUCT LAUNCHES
TABLE 623 INGREDION: DEALS
TABLE 624 INGREDION: EXPANSIONS
TABLE 625 INGREDION: OTHER DEVELOPMENTS
TABLE 626 TATE & LYLE: COMPANY OVERVIEW
TABLE 627 TATE & LYLE: PRODUCTS OFFERED
TABLE 628 TATE & LYLE: PRODUCT LAUNCHES
TABLE 629 TATE & LYLE: DEALS
TABLE 630 TATE & LYLE: EXPANSIONS
TABLE 631 TATE & LYLE: OTHER DEVELOPMENTS
TABLE 632 ROQUETTE FRERES: COMPANY OVERVIEW
TABLE 633 ROQUETTE FRERES: PRODUCTS OFFERED
TABLE 634 ROQUETTE FRERES: PRODUCT LAUNCHES
TABLE 635 ROQUETTE FRERES: DEALS
TABLE 636 ROQUETTE FRERES: EXPANSIONS
TABLE 637 ROQUETTE FRERES: OTHER DEVELOPMENTS
TABLE 638 ASSOCIATED BRITISH FOODS PLC: COMPANY OVERVIEW
TABLE 639 ASSOCIATED BRITISH FOODS PLC: PRODUCTS OFFERED
TABLE 640 ASSOCIATED BRITISH FOODS PLC: PRODUCT LAUNCHES
TABLE 641 ASSOCIATED BRITISH FOODS PLC: DEALS
TABLE 642 ASSOCIATED BRITISH FOODS PLC: EXPANSIONS
TABLE 643 ASSOCIATED BRITISH FOODS PLC: OTHER DEVELOPMENTS
TABLE 644 FONTERRA CO-OPERATIVE GROUP LIMITED: COMPANY OVERVIEW
TABLE 645 FONTERRA CO-OPERATIVE GROUP LIMITED: PRODUCTS OFFERED
TABLE 646 FONTERRA CO-OPERATIVE GROUP LIMITED: PRODUCT LAUNCHES
TABLE 647 FONTERRA CO-OPERATIVE GROUP LIMITED: DEALS
TABLE 648 FONTERRA CO-OPERATIVE GROUP LIMITED: EXPANSIONS
TABLE 649 FONTERRA CO-OPERATIVE GROUP LIMITED: OTHER DEVELOPMENTS
TABLE 650 KERRY GROUP PLC: COMPANY OVERVIEW
TABLE 651 KERRY GROUP PLC: PRODUCTS OFFERED
TABLE 652 KERRY GROUP PLC: PRODUCT LAUNCHES
TABLE 653 KERRY GROUP PLC: DEALS
TABLE 654 KERRY GROUP PLC: EXPANSIONS
TABLE 655 KERRY GROUP PLC: OTHER DEVELOPMENTS
TABLE 656 NOVONESIS GROUP: COMPANY OVERVIEW
TABLE 657 NOVONESIS GROUP: PRODUCTS OFFERED
TABLE 658 NOVONESIS GROUP: PRODUCT LAUNCHES
TABLE 659 NOVONESIS GROUP: DEALS
TABLE 660 NOVONESIS GROUP: EXPANSIONS
TABLE 661 NOVONESIS GROUP: OTHER DEVELOPMENTS
TABLE 662 BALCHEM CORP.: COMPANY OVERVIEW
TABLE 663 BALCHEM CORP.: PRODUCTS OFFERED
TABLE 664 BALCHEM CORP.: PRODUCT LAUNCHES
TABLE 665 BALCHEM CORP.: DEALS
TABLE 666 BALCHEM CORP.: EXPANSIONS
TABLE 667 BALCHEM CORP.: OTHER DEVELOPMENTS
TABLE 668 AJINOMOTO CO., INC.: COMPANY OVERVIEW
TABLE 669 AJINOMOTO CO., INC.: PRODUCTS OFFERED
TABLE 670 AJINOMOTO CO., INC.: DEALS
TABLE 671 AJINOMOTO CO., INC.: EXPANSIONS
TABLE 672 AJINOMOTO CO., INC.: OTHER DEVELOPMENTS
TABLE 673 DIVI'S LABORATORIES LIMITED: COMPANY OVERVIEW
TABLE 674 DIVI'S LABORATORIES LIMITED: PRODUCTS OFFERED
TABLE 675 DIVI'S LABORATORIES LIMITED: DEALS
TABLE 676 DIVI'S LABORATORIES LIMITED: EXPANSIONS
TABLE 677 KEMIN INDUSTRIES, INC.: COMPANY OVERVIEW
TABLE 678 KEMIN INDUSTRIES, INC.: PRODUCTS OFFERED
TABLE 679 KEMIN INDUSTRIES, INC.: PRODUCT LAUNCHES
TABLE 680 KEMIN INDUSTRIES, INC.: DEALS
TABLE 681 KEMIN INDUSTRIES, INC.: OTHER DEVELOPMENTS
TABLE 682 GELITA: COMPANY OVERVIEW
TABLE 683 GELITA: PRODUCTS OFFERED
TABLE 684 GELITA: PRODUCT LAUNCHES
TABLE 685 GELITA: DEALS
TABLE 686 GELITA: EXPANSIONS
TABLE 687 GELITA: OTHER DEVELOPMENTS
TABLE 688 BENEO: COMPANY OVERVIEW
TABLE 689 BENEO: PRODUCTS OFFERED
TABLE 690 BENEO: PRODUCT LAUNCHES
TABLE 691 BENEO: DEALS
TABLE 692 BENEO: EXPANSIONS
TABLE 693 BENEO: OTHER DEVELOPMENTS
TABLE 694 COSUCRA: COMPANY OVERVIEW
TABLE 695 CONAGEN, INC.: COMPANY OVERVIEW
TABLE 696 SARSHIKA PHARMACHEM LLP: COMPANY OVERVIEW
TABLE 697 CANURTA NATURALS USA: COMPANY OVERVIEW
TABLE 698 EVANIUM: COMPANY OVERVIEW
TABLE 699 ADJACENT MARKETS TO NUTRACEUTICAL INGREDIENTS MARKET
TABLE 700 PROTEIN INGREDIENTS MARKET, BY REGION, 2022-2025 (USD MILLION)
TABLE 701 PROTEIN INGREDIENTS MARKET, BY REGION, 2026-2031 (USD MILLION)
TABLE 702 PROTEIN INGREDIENTS MARKET, BY REGION, 2022-2025 (TONS)
TABLE 703 PROTEIN INGREDIENTS MARKET, BY REGION, 2026-2031 (TONS)
TABLE 704 NUTRACEUTICAL GUMMIES MARKET, BY INGREDIENT SOURCE, 2021-2024 (USD MILLION)
TABLE 705 NUTRACEUTICAL GUMMIES MARKET, BY INGREDIENT SOURCE, 2025-2030 (USD MILLION)

List of Figures

FIGURE 1 MARKET SEGMENTATION
FIGURE 2 MARKET SCENARIO
FIGURE 3 NUTRACEUTICAL INGREDIENTS MARKET, 2022-2031
FIGURE 4 MAJOR STRATEGIES ADOPTED BY KEY PLAYERS IN NUTRACEUTICAL INGREDIENTS MARKET, 2021-JUNE 2026
FIGURE 5 DISRUPTIONS INFLUENCING GROWTH NUTRACEUTICAL INGREDIENTS MARKET
FIGURE 6 NUTRACEUTICAL INGREDIENTS MARKET: HIGH-GROWTH SEGMENTS, 2026-2031
FIGURE 7 ASIA PACIFIC TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD
FIGURE 8 GROWING DEMAND FOR TARGETED NUTRITION AND FUNCTIONAL INGREDIENTS TO DRIVE MARKET GROWTH
FIGURE 9 FUNCTIONAL PROTEINS SEGMENT AND ASIA PACIFIC TO ACCOUNT FOR LARGEST MARKET SHARES IN 2026
FIGURE 10 PLANT-BASED SEGMENT TO LEAD MARKET IN 2026
FIGURE 11 FUNCTIONAL PROTEINS SEGMENT TO ACCOUNT FOR LARGEST MARKET SHARE IN 2026
FIGURE 12 HUMAN NUTRITION SEGMENT TO DOMINATE MARKET IN 2026
FIGURE 13 US TO ACCOUNT FOR LARGEST MARKET SHARE IN 2026
FIGURE 14 NUTRACEUTICAL INGREDIENTS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
FIGURE 15 SOURCES USED TO CONSUME SELECTED NUTRIENTS
FIGURE 16 NUTRACEUTICAL INGREDIENTS MARKET: PORTER'S FIVE FORCES ANALYSIS
FIGURE 17 GLOBAL CURRENT HEALTH EXPENDITURE AS A SHARE OF GDP, 2000-2023 (%)
FIGURE 18 REAL HOUSEHOLD INCOME PER CAPITA GROWTH IN OECD, Q2 2023-Q2 2025 (%)
FIGURE 20 NUTRACEUTICAL INGREDIENTS MARKET: MARKET MAP
FIGURE 21 AVERAGE SELLING PRICE TREND, BY INGREDIENT TYPE, 2022-2025 (USD/KG)
FIGURE 22 AVERAGE SELLING PRICE TREND, BY REGION (USD/KG)
FIGURE 23 EXPORT VALUE OF HS CODE 2936, BY KEY COUNTRY, 2021-2025 (USD MILLION)
FIGURE 24 IMPORT VALUE OF HS CODE 2936, BY KEY COUNTRY, 2021-2025 (USD MILLION)
FIGURE 25 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESS
FIGURE 26 INVESTMENT AND FUNDING SCENARIO, 2021-2026 (USD MILLION)
FIGURE 27 NUMBER OF PATENTS GRANTED FOR NUTRACEUTICAL INGREDIENTS MARKET, 2016-2026
FIGURE 28 REGIONAL ANALYSIS OF PATENTS GRANTED FOR NUTRACEUTICAL INGREDIENTS MARKET, 2016-2026
FIGURE 29 FUTURE APPLICATIONS
FIGURE 31 KEY BUYING CRITERIA FOR APPLICATION
FIGURE 32 ADOPTION BARRIERS AND INTERNAL CHALLENGES
FIGURE 33 NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE, 2026 VS. 2031
FIGURE 34 NUTRACEUTICAL INGREDIENTS MARKET, BY SOURCE, 2026 VS. 2031
FIGURE 35 NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2026 VS. 2031 (USD MILLION)
FIGURE 36 INDIA TO RECORD FASTEST GROWTH DURING FORECAST PERIOD
FIGURE 37 NORTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET SNAPSHOT
FIGURE 38 ASIA PACIFIC: NUTRACEUTICAL INGREDIENTS MARKET SNAPSHOT
FIGURE 39 BRAND/PRODUCT COMPARISON
FIGURE 40 NUTRACEUTICAL INGREDIENTS MARKET: REVENUE ANALYSIS FOR FIVE KEY PLAYERS, 2023-2025 (USD BILLION)
FIGURE 41 COMPANY VALUATION OF NUTRACEUTICAL INGREDIENTS PLAYERS
FIGURE 42 EV/EBITDA OF KEY COMPANIES
FIGURE 43 SHARE OF LEADING COMPANIES IN NUTRACEUTICAL INGREDIENTS MARKET, 2025
FIGURE 44 NUTRACEUTICAL INGREDIENTS MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2025
FIGURE 45 NUTRACEUTICAL INGREDIENTS MARKET: COMPANY FOOTPRINT
FIGURE 46 NUTRACEUTICAL INGREDIENTS MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2025
FIGURE 47 CARGILL, INCORPORATED: COMPANY SNAPSHOT
FIGURE 48 ADM: COMPANY SNAPSHOT
FIGURE 49 INTERNATIONAL FLAVORS & FRAGRANCES INC.: COMPANY SNAPSHOT
FIGURE 50 BASF: COMPANY SNAPSHOT
FIGURE 51 GLANBIA PLC: COMPANY SNAPSHOT
FIGURE 52 ARLA FOODS AMBA: COMPANY SNAPSHOT
FIGURE 53 DSM-FIRMENICH: COMPANY SNAPSHOT
FIGURE 54 INGREDION: COMPANY SNAPSHOT
FIGURE 55 TATE & LYLE: COMPANY SNAPSHOT
FIGURE 56 ROQUETTE FRERES: COMPANY SNAPSHOT
FIGURE 57 ASSOCIATED BRITISH FOODS PLC: COMPANY SNAPSHOT
FIGURE 58 FONTERRA CO-OPERATIVE GROUP LIMITED: COMPANY SNAPSHOT
FIGURE 59 KERRY GROUP PLC: COMPANY SNAPSHOT
FIGURE 60 NOVONESIS GROUP: COMPANY SNAPSHOT
FIGURE 61 BALCHEM CORP.: COMPANY SNAPSHOT
FIGURE 62 AJINOMOTO CO., INC.: COMPANY SNAPSHOT
FIGURE 63 DIVI'S LABORATORIES LIMITED: COMPANY SNAPSHOT
FIGURE 64 NUTRACEUTICAL INGREDIENTS MARKET: RESEARCH DESIGN
FIGURE 65 KEY DATA FROM SECONDARY SOURCES
FIGURE 66 KEY DATA FROM PRIMARY SOURCES
FIGURE 67 INSIGHTS FROM INDUSTRY EXPERTS
FIGURE 68 BREAKDOWN OF PRIMARIES, BY COMPANY TYPE, DESIGNATION, AND REGION
FIGURE 69 NUTRACEUTICAL INGREDIENTS MARKET: BOTTOM-UP APPROACH
FIGURE 70 MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH
FIGURE 71 MARKET SIZE ESTIMATION METHODOLOGY: SUPPLY-SIDE ANALYSIS
FIGURE 72 MARKET SIZE ESTIMATION METHODOLOGY: DEMAND-SIDE ANALYSIS
FIGURE 73 DATA TRIANGULATION METHODOLOGY

Nutraceutical Ingredients Market by Ingredient Type (Functional Proteins, Amino Acids, Probiotics, Others), Application (Human Nutrition, Animal Nutrition), Source (Plant-Based, Animal-Based, Others), Function, and Region - Global Forecast to 2031

Description

Table of Contents

List of Tables

The report provides insights into the following pointers:

TABLE OF CONTENTS

1 INTRODUCTION

2 EXECUTIVE SUMMARY

3 PREMIUM INSIGHTS

4 MARKET OVERVIEW

5 INDUSTRY TRENDS

6 REGULATORY AND SUSTAINABILITY LANDSCAPE

7 TECHNOLOGICAL ADVANCEMENTS, AI-DRIVEN IMPACT, PATENTS, INNOVATIONS, AND FUTURE APPLICATIONS

8 CUSTOMER LANDSCAPE AND BUYER BEHAVIOR

9 NUTRACEUTICAL INGREDIENTS MARKET, BY FUNCTION

10 NUTRACEUTICAL INGREDIENTS MARKET, BY INGREDIENT TYPE

11 NUTRACEUTICAL INGREDIENTS MARKET, BY SOURCE

12 NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION

13 NUTRACEUTICAL INGREDIENTS MARKET, BY REGION

14 COMPETITIVE LANDSCAPE

15 COMPANY PROFILES

16 RESEARCH METHODOLOGY

17 ADJACENT & RELATED MARKETS

18 APPENDIX

List of Tables

List of Figures